0001161697-16-001079.txt : 20160916 0001161697-16-001079.hdr.sgml : 20160916 20160915181730 ACCESSION NUMBER: 0001161697-16-001079 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 45 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160916 DATE AS OF CHANGE: 20160915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AngioSoma, Inc. CENTRAL INDEX KEY: 0001502152 STANDARD INDUSTRIAL CLASSIFICATION: CRUDE PETROLEUM & NATURAL GAS [1311] IRS NUMBER: 273480481 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-55072 FILM NUMBER: 161887939 BUSINESS ADDRESS: STREET 1: 14001 WALDEN RD., SUITE 600 CITY: MONTGOMERY STATE: TX ZIP: 77356 BUSINESS PHONE: 832-781-8521 MAIL ADDRESS: STREET 1: 14001 WALDEN RD., SUITE 600 CITY: MONTGOMERY STATE: TX ZIP: 77356 FORMER COMPANY: FORMER CONFORMED NAME: First Titan Corp. DATE OF NAME CHANGE: 20100927 10-Q/A 1 form_10-q.htm FORM 10-Q/A AMENDMENT NO. 1 TO QUARTERLY REPORT FOR 06-30-2016

UNITED STATES

SECURITY AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q /A

Amendment No. 1

 

(MARK ONE)

 

þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2016

 

or

 

o   TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to _________

 

Commission File Number: 333-170315

 

 

AngioSoma Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

 

27-3480481

(State or other jurisdiction of Incorporation or organization)

 

(I.R.S. Employer Identification Number)

 

 

 

14001 Walden Rd., Suite 600
Montgomery, Texas

 

77356

(Address of principal executive offices)

 

(Zip code)

 

Registrant’s telephone number, including area code: 832-781-8521

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes þ No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes þ No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

 

Large accelerated filer

o

Accelerated filer

o

 

Non-accelerated filer

o

Smaller reporting company

þ

 

(Do not check is smaller reporting company)

 

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)

Yes o No þ

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of September 13, 2016, 31,520,667  shares of common stock are issued and outstanding.




EXPLANATORY NOTE


The purpose of this Amendment No. 1 to the Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 (“Form 10-Q”) is to submit Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 consists of the Interactive Data Files from the Registrant’s Form 10-Q for the quarterly period ended June 30, 2016, filed with the Securities and Exchange Commission on September 13, 2016.



ITEM 6. EXHIBITS


3.1

Articles of Incorporation (1)

3.2

Bylaws (2)

14.1

Code of Ethics (3)

31.1

Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer and principal financial and account officer. (4)

32.1

Section 1350 Certification of principal executive officer and principal financial accounting officer. (4)

101

XBRL data files of Financial Statement and Notes contained in this Quarterly Report on Form 10-Q. (5)

__________

(1)

Incorporated by reference to our Definitive Proxy Statement on Schedule 14A filed on April 8, 2015.

(2)

Incorporated by reference to our Form 10-K/A Amendment No. 1 for the year ended September 30, 2015 filed on January 22, 2016.

(3)

Incorporated by reference to our Form S-1 filed with the Securities and Exchange Commission on November 3, 2010.

(4)

Previously filed or furnished herewith.

(5)

In accordance with Regulation S-T, the Interactive Data Files in Exhibit 101 to the Quarterly Report on Form 10-Q shall be deemed “furnished” and not “filed.”


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 

AngioSoma Inc.

 

 

Date: September 15, 2016

BY: /s/ Alex Blankenship

 

Alex Blankenship

 

Chief Executive Officer, President, Secretary, Treasurer, Principal Executive Officer, Principal Finance and Accounting Officer and Sole Director


- 2 -


GRAPHIC 2 angiosoma_logo.jpg GRAPHIC begin 644 angiosoma_logo.jpg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soan-20160630.xml XBRL INSTANCE FILE 0001502152 2016-06-30 0001502152 us-gaap:CommonStockMember 2016-06-30 0001502152 us-gaap:AdditionalPaidInCapitalMember 2016-06-30 0001502152 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-06-30 0001502152 us-gaap:RetainedEarningsMember 2016-06-30 0001502152 us-gaap:ConvertibleNotesPayableMember 2016-06-30 0001502152 soan:ConvertibleNotesPayable1Member 2016-06-30 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable2Member 2016-06-30 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable3Member 2016-06-30 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable4Member 2016-06-30 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable5Member 2016-06-30 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable7Member 2016-06-30 0001502152 us-gaap:ConvertibleNotesPayableMember 2016-04-30 2016-06-30 0001502152 soan:ConvertibleNotesPayable1Member 2016-04-30 2016-06-30 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable2Member 2016-04-30 2016-06-30 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable3Member 2016-04-30 2016-06-30 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable4Member 2016-04-30 2016-06-30 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable5Member 2016-04-30 2016-06-30 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable7Member 2016-04-30 2016-06-30 0001502152 soan:MinnsProjectMember stpr:TX 2013-07-07 0001502152 soan:MinnsProjectMember stpr:TX 2013-07-06 2013-07-07 0001502152 us-gaap:SalesRevenueGoodsNetMember soan:OperatorOneMember 2016-04-30 2016-06-30 0001502152 us-gaap:SalesRevenueGoodsNetMember soan:OperatorTwoMember 2016-04-30 2016-06-30 0001502152 us-gaap:AccountsReceivableMember soan:OperatorOneMember 2016-04-30 2016-06-30 0001502152 us-gaap:AccountsReceivableMember soan:OperatorTwoMember 2016-04-30 2016-06-30 0001502152 2014-10-01 2015-09-30 0001502152 2013-10-01 2014-09-30 0001502152 2011-10-01 2012-09-30 0001502152 2012-10-01 2013-09-30 0001502152 us-gaap:FairValueInputsLevel1Member us-gaap:AvailableforsaleSecuritiesMember 2016-06-30 0001502152 us-gaap:FairValueInputsLevel1Member 2016-06-30 0001502152 us-gaap:FairValueInputsLevel3Member us-gaap:AssetRetirementObligationCostsMember 2016-06-30 0001502152 us-gaap:FairValueInputsLevel3Member 2016-06-30 0001502152 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember 2016-06-30 0001502152 us-gaap:FairValueInputsLevel3Member us-gaap:AvailableforsaleSecuritiesMember 2016-06-30 0001502152 us-gaap:FairValueInputsLevel2Member 2016-06-30 0001502152 us-gaap:FairValueInputsLevel1Member us-gaap:AssetRetirementObligationCostsMember 2016-06-30 0001502152 us-gaap:FairValueInputsLevel2Member us-gaap:AssetRetirementObligationCostsMember 2016-06-30 0001502152 us-gaap:AssetRetirementObligationCostsMember 2016-04-30 2016-06-30 0001502152 us-gaap:AvailableforsaleSecuritiesMember 2016-04-30 2016-06-30 0001502152 soan:ParticipationAgreementMember country:LA 2012-01-03 0001502152 soan:ParticipationAgreementMember country:LA 2012-01-02 2012-01-03 0001502152 soan:ParticipationAgreementMember country:LA 2013-08-11 2013-08-12 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable9Member 2016-06-30 0001502152 soan:VistaViewVenturesIncMember soan:ConvertibleNotesPayable9Member 2016-04-30 2016-06-30 0001502152 2016-09-13 0001502152 us-gaap:SeriesAPreferredStockMember 2016-06-30 0001502152 us-gaap:SeriesEPreferredStockMember 2016-06-30 0001502152 2016-04-30 2016-06-30 0001502152 2016-04-29 0001502152 us-gaap:CommonStockMember 2016-04-30 2016-06-30 0001502152 us-gaap:CommonStockMember 2016-04-29 0001502152 us-gaap:SeriesAPreferredStockMember 2016-04-30 2016-06-30 0001502152 us-gaap:SeriesAPreferredStockMember 2016-04-29 0001502152 us-gaap:SeriesEPreferredStockMember 2016-04-30 2016-06-30 0001502152 us-gaap:SeriesEPreferredStockMember 2016-04-29 0001502152 us-gaap:AdditionalPaidInCapitalMember 2016-04-30 2016-06-30 0001502152 us-gaap:AdditionalPaidInCapitalMember 2016-04-29 0001502152 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-04-30 2016-06-30 0001502152 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-04-29 0001502152 us-gaap:RetainedEarningsMember 2016-04-30 2016-06-30 0001502152 us-gaap:RetainedEarningsMember 2016-04-29 0001502152 soan:AngioSomaResearchIncMember 2016-06-03 0001502152 soan:AngioSomaResearchIncMember 2016-06-02 2016-06-03 0001502152 soan:FirstTitanCorpMember 2016-06-03 0001502152 us-gaap:IntellectualPropertyMember us-gaap:SeriesAPreferredStockMember 2016-04-28 2016-04-29 0001502152 soan:ConvertibleNotesPayable2Member 2016-04-30 2016-06-30 0001502152 soan:ConvertibleNotesPayable7Member 2016-06-27 2016-06-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft soan:Number 8789 4440 1250 14479 2990535 13002 33742 234317 3252333 143188 15577 21650 11000 35000 52137 15000 662607 23946 6116 713110 31521 -395451 -4464 -83918 3252333 116673 128358 143438 376773 0.0010 480000000 31520667 31520667 0.001 20000000 200575 369055 20441 31520667 121 386 108 1665 18780547 -0.00 -83918 -83918 59676 -24242 25907 25292 -88382 -4464 31520667 5000000 1000000 10022543 1000000 2539223 31521 -395451 -4464 -83918 11023 10023 1000 2990535 2990535 2990535 20000000 -381444 20000 -401444 20000000 1498124 7491 1498 5993 -4464 -4464 5000000 5000000 4464 480921 2990535 8789 15100 15100 5690 5690 -12001 7642 12138 404 52034 507 75 7491 <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note 1. General Organization and Business</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">AngioSoma Inc., a Nevada corporation, is a clinical stage biotechnology company focused on improving the effectiveness of current standard-of-care treatments, especially related to endovascular interventions in the treatment of peripheral artery disease (PAD).</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">AngioSoma Nevada is developing its lead product, a drug candidate called Liprostin<sup>TM</sup>&#160;for the treatment of peripheral artery disease, or PAD, which has completed FDA Phase I and three Phase II clinical trials. We are in discussions with several contract research organizations for completion of our FDA protocol for Phase III and submission of our new drug application for marketing in the US and its territories.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company incorporated on April 29, 2016. The Company&#146;s year-end is September 30.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">On June 3, 2016, we entered into a business combination whereby a wholly-owned subsidiary of the Company, AngioSoma Research, Inc., a Texas corporation, (&#147;AngioSoma Texas&#148;) merged with AngioSoma Research, Inc., a Nevada corporation, (&#147;AngioSoma Nevada&#148;) with AngioSoma Research Texas surviving as our wholly-owned subsidiary (the &#147;Merger&#148;) . In connection with the Merger, the Company issued to the holders of outstanding common stock of AngioSoma Nevada 20 million shares of the Company&#146;s common stock (&#147;Common Stock&#148;) and, as a result, immediately following the completion of the Merger, the former equity holders of AngioSoma Nevada owned approximately 66% of the Common Stock and the stockholders of First Titan Corp. immediately prior to the Merger owned approximately 34% of the Common Stock, in each case, on a fully-diluted basis (subject to certain exceptions and adjustments).&#160; Also in connection with the Merger, the pre-Merger director and officer of the Company tendered his resignation and the pre-Merger director and officer of AngioSoma Nevada was appointed as the new director and officer of the Company, and our corporate headquarters was moved from Las Vegas, Nevada to Montgomery, Texas. In connection with completion of the Merger, the Company changed its corporate name from First Titan Corp. to AngioSoma, Inc. and its common stock continues to trade on the OTC Markets Group, OTCQB tier under the new trading symbol &#147;SOAN&#148;.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">First Titan Energy&#146;s oil and gas development activities include the following:</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><u>Alabama</u>&#160;&#150; On May 2, 2012, we acquired a one percent working interest in one well in Little Cedar Creek Field in Alabama. This well was drilled during the fiscal year ended September 30, 2012 and we began receiving revenue during the fiscal year ended September 30, 2013. This well is located in the Little Cedar Field, Alabama&#146;s largest producing oil field. This well is currently producing oil and natural gas from one well.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><u>Louisiana</u>&#160;&#150; On January 3, 2012, we entered into a participation agreement in an oil and gas drilling project in Calcasieu Parish, Louisiana (the &#147;Participation Agreement&#148;). The South Lake Charles Prospect is located seven miles south of the city of Lake Charles, Louisiana. It is a middle Oligocene age geo-pressured prospect located in the middle and lower hackberry sands. Under the terms of the Participation Agreement, we will participate in the drilling of one well and may participate in the drilling of future wells if it chooses. We will pay 25% of the drilling cost of the first well and will receive 13.59% of the net revenue from the well. We anticipate that our share of the total drilling and completion cost of the initial well, projected to be drilled to approximately 15,500 feet, will be $3.4 million. On August 12, 2013, the Participation Agreement was amended to reduce our working interest to 1.8%. As a result, our share of the drilling cost is expected to be approximately $181,000. The Company has paid $143,264 of its share of the costs of the well to date. We will receive 1.4% of the revenue from this well. The well began being drilled during the year ended September 30, 2014. During the year ended September 30, 2015, before the completion of the well, the well was damaged by a subcontractor working on the well. The operator of the well is in arbitration with the relevant subcontractors for compensation on the damage to the well.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><u>Texas</u>&#160;&#150; On July 7, 2013, the Company acquired a 30% working interest in the Minns Project located in Waller County, Texas. The project included three producing wells and a salt water disposal well within the Brookshire Field. This well was reworked and deepened during the year ended September 30, 2014. It is currently producing oil from one well.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note 2. Going Concern</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. For the period from inception (April 29, 2016) through June 30, 2016, the Company had a net loss of $83,918 and negative cash flow from operating activities of $12,001. As of June 30, 2016, the Company had negative working capital of $648,128. Management does not anticipate having positive cash flow from operations in the near future.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">These factors raise a substantial doubt about the Company&#146;s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Management has plans to address the Company&#146;s financial situation as follows:</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">In the near term, management plans to continue to focus on raising the funds necessary to implement the Company&#146;s business plan. Management will continue to seek out debt financing to obtain the capital required to meet the Company&#146;s financial obligations. There is no assurance, however, that lenders will continue to advance capital to the Company or that the new business operations will be profitable. The possibility of failure in obtaining additional funding and the potential inability to achieve profitability raise doubts about the Company&#146;s ability to continue as a going concern.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">In the long term, management believes that the Company&#146;s projects and initiatives will be successful and will provide cash flow to the Company, which will be used to finance the Company&#146;s future growth. However, there can be no assurances that the Company&#146;s planned activities will be successful, or that the Company will ultimately attain profitability. The Company&#146;s long-term viability depends on its ability to obtain adequate sources of debt or equity funding to meet current commitments and fund the continuation of its business operations, and the ability of the Company to achieve adequate profitability and cash flows from operations to sustain its operations.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note 3. Summary of Significant Accounting Policies</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Interim Financial Statements</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;GAAP&#148;) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. The results of operations for the period from inception (April 29, 2016) through June 30, 2016 are not necessarily indicative of the results to be expected for the full fiscal year ending September 30, 2016.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Consolidated Financial Statements</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, AngioSoma Research, LLC, First Titan Energy, LLC and First Titan Technical, LLC from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Use of Estimates</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Credit Risk due to Certain Concentrations</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">We extend credit, primarily in the form of uncollateralized oil and gas sales through the operators of our working interests, to various companies in the oil and gas industry, which results in a concentration of credit risk. The concentration of credit risk may be affected by changes in economic or other conditions within our industry and may accordingly affect our overall credit risk. However, we believe that the risk of these unsecured receivables is mitigated by the nature of the companies to which we extend credit. For the period from inception (April 29, 2016) through June 30, 2016, two operators accounted for 54% and 46% of our oil and gas sales. Those operators account for 35% and 65% of accounts receivable as of June 30, 2016. We did not recognize any credit losses during the period from inception (April 29, 2016) through June 30, 2016. We have not recognized an allowance for doubtful accounts as of June 30, 2016.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Oil and Gas Properties</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company follows the full cost method of accounting for its oil and gas properties, whereby all costs incurred in connection with the acquisition, exploration for and development of petroleum and natural gas reserves are capitalized. Such costs include lease acquisition, geological and geophysical activities, rentals on non-producing leases, drilling, completing, and equipping of oil and gas wells and administrative costs directly attributable to those activities and asset retirement costs. Disposition of oil and gas properties are accounted for as a reduction of capitalized costs, with no gain or loss recognized unless such adjustment would significantly alter the relationship between capital costs and proved reserves of oil, in which case the gain or loss is recognized in the statement of operations.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Depletion of capitalized oil and gas properties and estimated future development costs, excluding unproved properties, are based on the units-of-production method based on proved reserves. The company recognized $386 of depletion during the period from inception (April 29, 2016) through June 30, 2016. Net capitalized costs of oil and gas properties, less related deferred taxes, are limited to the lower of unamortized cost or the cost ceiling, defined as the sum of the present value of estimated future net revenues from proved reserves based on unescalated prices discounted at ten percent, plus the cost of properties not being amortized, if any, plus the lower of cost or estimated fair value of unproved properties included in the costs being amortized, if any, less related income taxes. As of June 30, 2016, the Company has oil and gas properties in the amount of $200,575, which are being excluded from amortization because they have not been evaluated to determine whether proved reserves are associated with those properties. Costs in excess of the present value of estimated future net revenues as discussed above are charged to impairment expense. The Company applies the full cost-ceiling test on a quarterly basis on the date of the latest balance sheet presented.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Based on management&#146;s review, 100% of the unproved oil and gas properties balance as of June 30, 2016 are expected to be added to amortization during the year ending September 30, 2016. The table below sets forth the cost of unproved properties excluded from the amortization base as of June 30, 2016 and notes the year in which the associated costs were incurred:</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; margin-top: 0px"> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="11" style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Year of Acquisition</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2012</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2013</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2014</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2015</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: top; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; width: 24%"><font style="font: 10pt Times New Roman, Times, Serif">Acquisition costs</font></td> <td style="vertical-align: top; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">153,264</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">47,311</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">200,575</font></td> <td style="vertical-align: top; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Development costs</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Exploration costs</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">153,264</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">47,311</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">200,575</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Asset retirement costs are recognized when the asset is placed in service, and are included in the amortization base and amortized over proved reserves using the units of production method. Asset retirement costs are estimated by management using existing regulatory requirements and anticipated future inflation rates.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Financial Instruments</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company&#146;s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period between the origination of these instruments and their expected realization.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">FASB Accounting Standards Codification (ASC) 820 <i>Fair Value Measurements and Disclosures</i> (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity&#146;s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:</font></p> <p style="text-align: justify; margin: 0"></p> <table cellspacing="0" cellpadding="0" style="font-size: 10pt; margin-top: 0px"> <tr style="font-size: 1pt"> <td style="width: 10%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 90%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 23.53px"><font style="font: 10pt Times New Roman, Times, Serif">Level 1 -</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 23.53px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 23.53px"><font style="font: 10pt Times New Roman, Times, Serif">Level 2 -</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 23.53px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 23.53px"><font style="font: 10pt Times New Roman, Times, Serif">Level 3 -</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Inputs that are both significant to the fair value measurement and unobservable.</font></td></tr> </table> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of June 30, 2016. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, other current assets, accounts payable, and accrued expenses. The fair value of the Company&#146;s notes payable is estimated based on current rates that would be available for debt of similar terms that is not significantly different from its stated value.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The following table presents assets that were measured and recognized at fair value as of June 30, 2016 and the period then ended on a recurring and nonrecurring basis:</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; margin-top: 0px"> <tr style="vertical-align: bottom"> <td style="border-bottom: rgb(0, 0, 0) 1px solid"><p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><u>June 30, 2016</u></b></font></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Description</b></font></p></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 1</b></font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 2</b></font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 3</b></font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total Realized Loss</b></font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; width: 38%"><font style="font: 10pt Times New Roman, Times, Serif">Asset retirement obligation</font></td> <td style="vertical-align: top; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">21,116</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 10%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td></tr> <tr> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Available for sale securities</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,002</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#151;</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#151;</b></font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Totals</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,002</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#151;</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>21,116</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td></tr> </table> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Revenue Recognition</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Sales of crude oil are recognized when the delivery to the purchaser has occurred and title has been transferred. This occurs when oil has been delivered to a pipeline or a tank lifting has occurred. Crude oil is priced on the delivery date based upon prevailing prices published by purchasers with certain adjustments related to oil quality and physical location.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Common Stock</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Income Taxes</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company accounts for income taxes under ASC 740 <i>Income Taxes</i>. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. No deferred tax assets or liabilities were recognized as of June 30, 2016.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Earnings (Loss) per Common Share</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company computes basic and diluted earnings per common share amounts in accordance with ASC Topic 260, <i>Earnings per Share</i>. The basic earnings (loss) per common share are calculated by dividing the Company&#146;s net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing the Company&#146;s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation. The Company&#146;s convertible debt is considered anti-dilutive due to the Company&#146;s net loss for the period from inception (April 29, 2016) through June30, 2016. As a result, the Company did not have any potentially dilutive common shares for that period. At June 30, 2016, the Company had 32,762,153 potentially issuable shares upon the conversion of convertible notes payable and interest.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Beneficial Conversion Feature</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Beneficial conversion feature is a non-detachable conversion feature that is in the money at the commitment date. The Company follows the guidance of ASC Subtopic 470-20 <i>Debt with Conversion and Other Options</i> to evaluate as to whether beneficial conversion feature exists. Pursuant to Section 470-20-30 an embedded beneficial conversion feature recognized separately under paragraph 470-20-25-5 shall be measured initially at its intrinsic value at the commitment date (see paragraphs 470-20-30-9 through 30-12) as the difference between the conversion price (see paragraph 470-20-30-5) and the fair value of the common stock or other securities into which the security is convertible, multiplied by the number of shares into which the security is convertible. When the Company issues a debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company&#146;s common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Commitments and Contingencies</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. There are no known commitments or contingencies as of June 30, 2016.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Recently Issued Accounting Pronouncements</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">We have reviewed the FASB issued Accounting Standards Update (&#147;ASU&#148;) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation&#146;s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Subsequent events</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR..</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note 4. Acquisition</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">On June 3, 2016, we entered into a business combination whereby a wholly-owned subsidiary of the Company, AngioSoma Research, Inc., a Texas corporation, (&#147;AngioSoma Texas&#148;) merged with AngioSoma Research, Inc., a Nevada corporation, (&#147;AngioSoma Nevada&#148;) with AngioSoma Research Texas surviving as our wholly-owned subsidiary (the &#147;Merger&#148;) . In connection with the Merger, the Company issued to the holders of outstanding common stock of AngioSoma Nevada 20 million shares of the Company&#146;s common stock (&#147;Common Stock&#148;) and, as a result, immediately following the completion of the Merger, the former equity holders of AngioSoma Nevada owned approximately 66% of the Common Stock and the stockholders of First Titan Corp. immediately prior to the Merger owned approximately 34% of the Common Stock, in each case, on a fully-diluted basis (subject to certain exceptions and adjustments).&#160; Also in connection with the Merger, the pre-Merger director and officer of the Company tendered his resignation and the pre-Merger director and officer of AngioSoma Nevada was appointed as the new director and officer of the Company, and our corporate headquarters was moved from Las Vegas, Nevada to Montgomery, Texas. In connection with completion of the Merger, the Company changed its corporate name from First Titan Corp. to AngioSoma, Inc. and its common stock continues to trade on the OTC Markets Group, OTCQB tier under the new trading symbol &#147;SOAN&#148;.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">For accounting purposes, the Merger is treated as a &#147;reverse acquisition&#148; under generally acceptable accounting principles in the United States (&#147;U.S. GAAP&#148;) and AngioSoma Nevada is considered the accounting acquirer. Accordingly, AngioSoma&#146;s historical results of operations will replace the Company&#146;s historical results of operations for all periods prior to the Merger and, for all periods following the Merger, the results of operations of the combined company will be included in the Company&#146;s financial statements.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note 5. Intellectual Property</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">On April 29, 2016, an individual contributed certain medical intellectual property to the Company in exchange for 5,000,000 shares of Series A Preferred Stock. The transaction was valued at $2,990,535 based upon the value of the Series A Preferred Stock as determined by a valuation expert.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note 6. Advances Payable to Related Party</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">During the period from inception (April 29, 2016) through June 30, 2016, the Company received non-interest bearing advances from a shareholder of the Company in the amount of $11,000. The advances remained outstanding as of June 30, 2016.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note 7. Advances </b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2016, the Company had non-interest bearing advances payable to a third party of $21,650. These advances are payable on demand.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note 8. Convertible Notes Payable</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Convertible notes payable consisted of the following at June 30, 2016:</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font-size: 10pt; margin-top: 0px"> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated September 30, 2013 in the original principal amount of $528,434, maturing September 30, 2015, bearing interest at 10% per year, convertible into common stock at a rate of $0.04 per share, in default.</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,324</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated June 30, 2014 payable in the original principal amount of $276,825, maturing June 30, 2016, bearing interest at 10% per year, convertible into common stock at a rate of $0.03 per share.</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">276,285</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated December 31, 2014 in the original principal amount of $118,620, maturing December 31, 2016, bearing interest at 10% per year, convertible into common stock at a rate of $0.01 per share.</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">118,620</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated March 31, 2015 in the original principal amount of $49,190, maturing March 31, 2017, bearing interest at 10% per year, convertible into common stock at a rate of $0.005 per share</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49,190</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated June 30, 2015 in the original principal amount of $66,074, maturing June 30, 2017, bearing interest at 10% per year, convertible into common stock at a rate of $0.53 per share</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">66,074</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated September 30, 2015 in the original principal amount of $235,313, maturing September 30, 2018, bearing interest at 10% per year, convertible into common stock a rate of $0.75 per share</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">235,313</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated December 31, 2015 in the original principal amount of $90,040, maturing December 31, 2018, bearing interest at 10% per year, convertible into common stock at a rate of $0.08 per share</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">90,040</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated March 31, 2016 in the original principal amount of $71,861, maturing March 31, 2019, bearing interest at 10% per year, convertible into common stock at a rate of a 60% discount to the market price on the date of conversion</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">71,861</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Total convertible notes payable</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">909,707</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Less: current portion of convertible notes payable</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(512,493</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Less: discount on noncurrent convertible notes payable</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(376,773</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Long-term convertible notes payable, net of discount</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">20,441</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Current portion of convertible notes payable</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">512,493</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Discount on current convertible notes payable</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(143,438</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Long-term convertible notes payable, net of discount</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">369,055</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="text-align: justify; margin: 0">&#160;</p> <p style="text-align: justify; margin: 0"></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">All principal along with accrued interest is payable on the maturity date. The notes are convertible into common stock at the option of the holder. The holder of the notes cannot convert the notes into shares of common stock if that conversion would result in the holder owning more than 4.9% of the outstanding stock of the Company.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Conversions to Common Stock</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">During period from inception (April 29, 2016) through June 30, 2016, the holders of the Convertible Note Payable dated December 31, 2014 elected to convert accrued interest of $7,491 into 1,498,124 shares of common stock. No gain or loss was recognized on the conversions as they occurred within the terms of the agreement that provided for conversion.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note 9. Stockholders&#146; Equity</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Common stock issued for reverse acquisition</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">On June 3, 2016, the Company issued 20,000,000 shares for the reverse acquisition of AngioSoma Nevada. See Note 4.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Common stock issued for conversion of convertible note payable</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">On June 28, 2016, the Company issued 1,498,124 shares of common stock upon the conversion of accrued interest of $7,491. No gain or loss was recognized on the transaction because it was transacted within the terms of the convertible note payable.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Series A Preferred Stock</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">On April 29, 2016, an individual contributed certain medical intellectual property to the Company in exchange for 5,000,000 shares of Series A Preferred Stock. The transaction was valued at $2,990,535 based upon the value of the Series A Preferred Stock as determined by a valuation expert.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Note 10. Subsequent Events</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company has reviewed subsequent events through the filing of this report and has noted none that require disclosure.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Interim Financial Statements</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;GAAP&#148;) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. The results of operations for the period from inception (April 29, 2016) through June 30, 2016 are not necessarily indicative of the results to be expected for the full fiscal year ending September 30, 2016.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Consolidated Financial Statements</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, AngioSoma Research, LLC, First Titan Energy, LLC and First Titan Technical, LLC from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Use of Estimates</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Credit Risk due to Certain Concentrations</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">We extend credit, primarily in the form of uncollateralized oil and gas sales through the operators of our working interests, to various companies in the oil and gas industry, which results in a concentration of credit risk. The concentration of credit risk may be affected by changes in economic or other conditions within our industry and may accordingly affect our overall credit risk. However, we believe that the risk of these unsecured receivables is mitigated by the nature of the companies to which we extend credit. For the period from inception (April 29, 2016) through June 30, 2016, two operators accounted for 54% and 46% of our oil and gas sales. Those operators account for 35% and 65% of accounts receivable as of June 30, 2016. We did not recognize any credit losses during the period from inception (April 29, 2016) through June 30, 2016. We have not recognized an allowance for doubtful accounts as of June 30, 2016.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Oil and Gas Properties</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company follows the full cost method of accounting for its oil and gas properties, whereby all costs incurred in connection with the acquisition, exploration for and development of petroleum and natural gas reserves are capitalized. Such costs include lease acquisition, geological and geophysical activities, rentals on non-producing leases, drilling, completing, and equipping of oil and gas wells and administrative costs directly attributable to those activities and asset retirement costs. Disposition of oil and gas properties are accounted for as a reduction of capitalized costs, with no gain or loss recognized unless such adjustment would significantly alter the relationship between capital costs and proved reserves of oil, in which case the gain or loss is recognized in the statement of operations.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Depletion of capitalized oil and gas properties and estimated future development costs, excluding unproved properties, are based on the units-of-production method based on proved reserves. The company recognized $386 of depletion during the period from inception (April 29, 2016) through June 30, 2016. Net capitalized costs of oil and gas properties, less related deferred taxes, are limited to the lower of unamortized cost or the cost ceiling, defined as the sum of the present value of estimated future net revenues from proved reserves based on unescalated prices discounted at ten percent, plus the cost of properties not being amortized, if any, plus the lower of cost or estimated fair value of unproved properties included in the costs being amortized, if any, less related income taxes. As of June 30, 2016, the Company has oil and gas properties in the amount of $200,575, which are being excluded from amortization because they have not been evaluated to determine whether proved reserves are associated with those properties. Costs in excess of the present value of estimated future net revenues as discussed above are charged to impairment expense. The Company applies the full cost-ceiling test on a quarterly basis on the date of the latest balance sheet presented.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Based on management&#146;s review, 100% of the unproved oil and gas properties balance as of June 30, 2016 are expected to be added to amortization during the year ending September 30, 2016. The table below sets forth the cost of unproved properties excluded from the amortization base as of June 30, 2016 and notes the year in which the associated costs were incurred:</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; margin-top: 0px"> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="11" style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Year of Acquisition</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2012</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2013</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2014</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2015</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: top; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; width: 24%"><font style="font: 10pt Times New Roman, Times, Serif">Acquisition costs</font></td> <td style="vertical-align: top; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">153,264</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">47,311</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">200,575</font></td> <td style="vertical-align: top; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Development costs</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Exploration costs</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">153,264</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">47,311</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">200,575</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Asset retirement costs are recognized when the asset is placed in service, and are included in the amortization base and amortized over proved reserves using the units of production method. Asset retirement costs are estimated by management using existing regulatory requirements and anticipated future inflation rates.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Financial Instruments</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company&#146;s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period between the origination of these instruments and their expected realization.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">FASB Accounting Standards Codification (ASC) 820 <i>Fair Value Measurements and Disclosures</i> (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity&#146;s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font-size: 10pt; margin-top: 0px"> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 23.53px; width: 10%"><font style="font: 10pt Times New Roman, Times, Serif">Level 1 -</font></td> <td style="text-align: justify; width: 90%"><font style="font: 10pt Times New Roman, Times, Serif">Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 23.53px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 23.53px"><font style="font: 10pt Times New Roman, Times, Serif">Level 2 -</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 23.53px"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; padding-left: 23.53px"><font style="font: 10pt Times New Roman, Times, Serif">Level 3 -</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Inputs that are both significant to the fair value measurement and unobservable.</font></td></tr> </table> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of June 30, 2016. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, other current assets, accounts payable, and accrued expenses. The fair value of the Company&#146;s notes payable is estimated based on current rates that would be available for debt of similar terms that is not significantly different from its stated value.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The following table presents assets that were measured and recognized at fair value as of June 30, 2016 and the period then ended on a recurring and nonrecurring basis:</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; margin-top: 0px"> <tr style="vertical-align: bottom"> <td style="border-bottom: rgb(0, 0, 0) 1px solid"><p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><u>June 30, 2016</u></b></font></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Description</b></font></p></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 1</b></font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 2</b></font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 3</b></font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total Realized Loss</b></font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; width: 38%"><font style="font: 10pt Times New Roman, Times, Serif">Asset retirement obligation</font></td> <td style="vertical-align: top; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">21,116</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 10%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td></tr> <tr> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Available for sale securities</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,002</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#151;</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#151;</b></font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Totals</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,002</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#151;</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>21,116</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td></tr> </table> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Revenue Recognition</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Sales of crude oil are recognized when the delivery to the purchaser has occurred and title has been transferred. This occurs when oil has been delivered to a pipeline or a tank lifting has occurred. Crude oil is priced on the delivery date based upon prevailing prices published by purchasers with certain adjustments related to oil quality and physical location.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Common Stock</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Income Taxes</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company accounts for income taxes under ASC 740 <i>Income Taxes</i>. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. No deferred tax assets or liabilities were recognized as of June 30, 2016.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Earnings (Loss) per Common Share</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company computes basic and diluted earnings per common share amounts in accordance with ASC Topic 260, <i>Earnings per Share</i>. The basic earnings (loss) per common share are calculated by dividing the Company&#146;s net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing the Company&#146;s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation. The Company&#146;s convertible debt is considered anti-dilutive due to the Company&#146;s net loss for the period from inception (April 29, 2016) through June30, 2016. As a result, the Company did not have any potentially dilutive common shares for that period. At June 30, 2016, the Company had 32,762,153 potentially issuable shares upon the conversion of convertible notes payable and interest.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Beneficial Conversion Feature</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Beneficial conversion feature is a non-detachable conversion feature that is in the money at the commitment date. The Company follows the guidance of ASC Subtopic 470-20 <i>Debt with Conversion and Other Options</i> to evaluate as to whether beneficial conversion feature exists. Pursuant to Section 470-20-30 an embedded beneficial conversion feature recognized separately under paragraph 470-20-25-5 shall be measured initially at its intrinsic value at the commitment date (see paragraphs 470-20-30-9 through 30-12) as the difference between the conversion price (see paragraph 470-20-30-5) and the fair value of the common stock or other securities into which the security is convertible, multiplied by the number of shares into which the security is convertible. When the Company issues a debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company&#146;s common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Commitments and Contingencies</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. There are no known commitments or contingencies as of June 30, 2016.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Recently Issued Accounting Pronouncements</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">We have reviewed the FASB issued Accounting Standards Update (&#147;ASU&#148;) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation&#146;s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Subsequent events</b></font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The table below sets forth the cost of unproved properties excluded from the amortization base as of June 30, 2016 and notes the year in which the associated costs were incurred:</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; margin-top: 0px"> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="11" style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Year of Acquisition</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2012</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2013</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2014</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: bottom; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2015</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1.33px solid; vertical-align: top; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; width: 24%"><font style="font: 10pt Times New Roman, Times, Serif">Acquisition costs</font></td> <td style="vertical-align: top; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">153,264</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">47,311</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">200,575</font></td> <td style="vertical-align: top; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Development costs</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Exploration costs</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(255, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">153,264</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">47,311</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-top: rgb(0, 0, 0) 1.33px solid; border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">200,575</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">The following table presents assets that were measured and recognized at fair value as of June 30, 2016 and the period then ended on a recurring and nonrecurring basis:</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table align="center" cellspacing="0" cellpadding="0" style="font-size: 10pt; margin-top: 0px"> <tr style="vertical-align: bottom"> <td style="border-bottom: rgb(0, 0, 0) 1px solid"><p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b><u>June 30, 2016</u></b></font></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <p style="margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>Description</b></font></p></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 1</b></font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 2</b></font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Level 3</b></font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="2" style="border-bottom: rgb(0, 0, 0) 1px solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Total Realized Loss</b></font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; width: 38%"><font style="font: 10pt Times New Roman, Times, Serif">Asset retirement obligation</font></td> <td style="vertical-align: top; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 11%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 9%"><font style="font: 10pt Times New Roman, Times, Serif">21,116</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; width: 3%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right; width: 10%"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td></tr> <tr> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Available for sale securities</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,002</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#151;</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#151;</b></font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">Totals</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">13,002</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#151;</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>21,116</b></font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#151;</font></td></tr> </table> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">Convertible notes payable consisted of the following at June 30, 2016:</font></p> <p style="text-align: justify; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellspacing="0" cellpadding="0" style="font-size: 10pt; margin-top: 0px"> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated September 30, 2013 in the original principal amount of $528,434, maturing September 30, 2015, bearing interest at 10% per year, convertible into common stock at a rate of $0.04 per share, in default.</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,324</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated June 30, 2014 payable in the original principal amount of $276,825, maturing June 30, 2016, bearing interest at 10% per year, convertible into common stock at a rate of $0.03 per share.</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">276,285</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated December 31, 2014 in the original principal amount of $118,620, maturing December 31, 2016, bearing interest at 10% per year, convertible into common stock at a rate of $0.01 per share.</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">118,620</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated March 31, 2015 in the original principal amount of $49,190, maturing March 31, 2017, bearing interest at 10% per year, convertible into common stock at a rate of $0.005 per share</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">49,190</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated June 30, 2015 in the original principal amount of $66,074, maturing June 30, 2017, bearing interest at 10% per year, convertible into common stock at a rate of $0.53 per share</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">66,074</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated September 30, 2015 in the original principal amount of $235,313, maturing September 30, 2018, bearing interest at 10% per year, convertible into common stock a rate of $0.75 per share</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">235,313</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated December 31, 2015 in the original principal amount of $90,040, maturing December 31, 2018, bearing interest at 10% per year, convertible into common stock at a rate of $0.08 per share</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">90,040</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Convertible note dated March 31, 2016 in the original principal amount of $71,861, maturing March 31, 2019, bearing interest at 10% per year, convertible into common stock at a rate of a 60% discount to the market price on the date of conversion</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">71,861</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Total convertible notes payable</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">909,707</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Less: current portion of convertible notes payable</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(512,493</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Less: discount on noncurrent convertible notes payable</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(376,773</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Long-term convertible notes payable, net of discount</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">20,441</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Current portion of convertible notes payable</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">512,493</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="background-color: white"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Discount on current convertible notes payable</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 1px solid; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(143,438</font></td> <td style="vertical-align: top; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="background-color: rgb(225, 255, 255)"> <td style="vertical-align: top; text-align: justify; padding-left: 10.53px; text-indent: -10.53px"><font style="font: 10pt Times New Roman, Times, Serif">Long-term convertible notes payable, net of discount</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: rgb(0, 0, 0) 3px double; vertical-align: bottom; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">369,055</font></td> <td style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> 0001502152 10-Q SOAN 2016-06-30 false --09-30 No No Yes Smaller Reporting Company Q3 2016 AngioSoma, Inc. 3 1 0.25 0.1359 0.014 15500 3400000 181000 0.018 143264 0.30 0.66 0.34 -12001 -648128 153264 47311 153264 47311 200575 200575 21116 13002 13002 21116 0.54 0.46 0.35 0.65 32762153 909707 2324 276285 118620 49190 66074 235313 90040 71861 512493 2013-09-30 2014-06-30 2014-12-31 2015-03-31 2015-06-30 2015-09-30 2015-12-31 2016-03-31 528434 276825 118620 49190 66074 235313 90040 71861 0.04 0.03 0.01 0.005 0.53 0.75 0.08 0.60 0.049 7491 7491 1498124 1498124 1000 1000000 1000000 5000000 5000000 2990535 EX-101.SCH 4 soan-20160630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - General Organization and Business link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Acquisition link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Intellectual Property link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Advances Payable to Related Party link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Advances link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Convertible Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Convertible Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - General Organization and Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Summary of Significant Accounting Policies (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Acquisition (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Intellectual Property (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Advances Payable to Related Party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Advances (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Convertible Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Convertible Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 soan-20160630_cal.xml XBRL CALCULATION FILE EX-101.DEF 6 soan-20160630_def.xml XBRL DEFINITION FILE EX-101.LAB 7 soan-20160630_lab.xml XBRL LABEL FILE Common Stock [Member] Equity Components [Axis] Additional Paid In Capital [Member] Accumulated Other Comprehensive Income [Member] Accumulated Deficit [Member] 10% Convertible Note Payable Due September 30, 2015 [Member] Debt Instrument [Axis] 10% Convertible Note Payable Due June 30, 2016 [Member] Vista View Ventures, Inc. [Member] Legal Entity [Axis] 10% Convertible Note Payable Due December 31, 2016 [Member] 10% Convertible Note Payable Due March 31, 2017 [Member] 10% Convertible Note Payable Due June 30, 2017 [Member] 10% Convertible Note Payable Due September 30, 2018 [Member] 10% Convertible Note Payable Due December 31, 2018 [Member] Minns Project [Member] Project [Axis] Waller County, Texas [Member] Geographical [Axis] Sales [Member] Concentration Risk Benchmark [Axis] Operator One [Member] Customer [Axis] Operator Two [Member] Accounts Receivable [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Hierarchy [Axis] Available For Sale Securities [Member] Asset Class [Axis] Fair Value, Inputs, Level 3 [Member] Asset Retirement Obligation [Member] Liability Class [Axis] Fair Value, Inputs, Level 2 [Member] Participation Agreement [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Calcasieu Parish, Louisiana [Member] 10% Convertible Note Payable Due March 31, 2019 [Member] Series A Preferred Stock [Member] Series E Preferred Stock [Member] Additional Paid-In Capital [Member] AngioSoma Research Nevada [Member] Business Acquisition [Axis] First Titan Corp [Member] Medical Intellectual Property [Member] Finite-Lived Intangible Assets by Major Class [Axis] Convertible Notes Payable [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Trading Symbol Document Period End Date Amendment Flag Current Fiscal Year End Date Entity a Well-known Seasoned Issuer Entity a Voluntary Filer Entity's Reporting Status Current Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents Accounts receivable and accrued revenue receivable Prepaid expenses Total current assets Intellectual property Available for sale securities, full cost method of accounting: Oil and gas properties Evaluated property, net of accumulated depletion of $116,673 and net of accumulated impairment of $128,358 Unevaluated property Total oil and gas properties TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) CURRENT LIABILITIES Accounts payable and accrued liabilities Accounts payable to related party Advances payable Advances payable to related party Current portion of convertible notes payable, net of discount of $143,438 Short term notes payable Current portion of accrued interest payable Current portion of asset retirement obligation Total current liabilities Convertible notes payable, net of discount of $376,773 Accrued interest payable Asset retirement obligation TOTAL LIABILITIES COMMITMENTS AND CONTINGENCIES STOCKHOLDERS' EQUITY (DEFICIT) Common stock, $0.0010 par value; 480,000,000 shares authorized; 31,520,667 shares issued and outstanding at June 30, 2016 Preferred stock; $0.001 par value; 20,000,000 shares authorized Series A Preferred stock; 5,000,000 shares issued and outstanding Series E Preferred stock; 1,000,000 shares issued and outstanding Additional paid-in capital Accumulated other comprehensive income Accumulated deficit Total stockholders' equity (deficit) TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Evaluated property, accumulated depletion Evaluated property, accumulated impairment Current portion of convertible notes payable, discount Noncurrent portion of convertible notes payable, discount Common stock, par value (in dollars per share) Common stock, authorized Common stock, issued Common stock, outstanding Preferred stock, par value (in dollars per share) Preferred stock, authorized Series A Preferred stock, issued Series A Preferred stock, outstanding Series E Preferred stock, issued Series E Preferred stock, outstanding Income Statement [Abstract] OIL AND GAS SALES, net OPERATING EXPENSES Lease operating expense Depletion, depreciation and amortization Accretion expense General and administrative expenses Total operating expenses LOSS FROM OPERATIONS OTHER INCOME (EXPENSE) Interest expense NET LOSS NET LOSS PER COMMON SHARE - Basic and diluted (in dollars per share) COMMON SHARES OUTSTANDING - Basic and diluted (in shares) Consolidated Statements Of Comprehensive Income NET LOSS Change in fair value of available-for-sale securities Comprehensive loss Statement [Table] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] BALANCE AT BEGINING BALANCE AT BEGINING (in shares) Net loss Other comprehensive loss Common stock issued for conversion of convertible note payable Common stock issued for conversion of convertible note payable (in shares) Common stock issued for acquisition Common stock issued for acquisition (in shares) Preferred stock issued for intellectual property Preferred stock issued for intellectual property (in shares) BALANCE AT END BALANCE AT END (in shares) Statement of Cash Flows [Abstract] CASH FLOW FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Depletion and accretion Amortization of discount on convertible note payable Changes in operating assets and liabilities: Accounts receivable and accrued revenue Accounts payable and accrued liabilities Accrued interest payable NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES Net cash received on acquisition of First Titan Corp. NET CASH USED IN INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from advances NET CASH PROVIDED BY FINANCING ACTIVITIES NET INCREASE (DECREASE) IN CASH CASH, at the beginning of the period CASH, at the end of the period Supplemental Disclosures of Cash Flow Information: Cash paid during the period for: Interest Taxes Noncash investing and financing transaction: Change in asset retirement obligation Conversion of accrued interest into common stock Intellectual property acquired with Series A Preferred Stock Common stock and preferred stock issued for reverse acquisition Change in fair value of available-for-sale securities Organization, Consolidation and Presentation of Financial Statements [Abstract] General Organization and Business Accounting Policies [Abstract] Going Concern Summary of Significant Accounting Policies Business Combinations [Abstract] Acquisition Goodwill and Intangible Assets Disclosure [Abstract] Intellectual Property Debt Disclosure [Abstract] Advances Payable to Related Party Advances Convertible Notes Payable Stockholders' Equity Note [Abstract] Stockholders' Equity Subsequent Events [Abstract] Subsequent Events Interim Financial Statements Consolidated Financial Statements Use of Estimates Credit Risk due to Certain Concentrations Oil and Gas Properties Financial Instruments Revenue Recognition Common Stock Income Taxes Earnings (Loss) per Common Share Beneficial Conversion Feature Commitments and Contingencies Recently Issued Accounting Pronouncements Subsequent events Schedule of cost of unproved properties excluded from the amortization base Schedule of assets measured and recognized at fair value on a recurring and nonrecurring basis Schedule of convertible notes payable Description of reverse stock split Reverse stock split, ratio Number of wells in processs fo drilling Percentage of oil and gas production expense Percentage of oil and gas revenue Projected drilling feet Total drilling and completion cost Percentage of reduce working interest Payment of oil and gas cost Percentage of working interest Number of common shares issued for aquisition Percentage of common stock owned Cash flow from operating activities Working capital Cost of unproved properties excluded from amortization, period costs: Acquisition costs Development costs Exploration costs Total Cost of unproved properties excluded from amortization, cumulative costs: Acquisition costs Development costs Exploration costs Total Liabilities ,fair value Assets , fair value Totals Total Realized Loss Concentration risk percentage Depletion expense Unevaluated properties Potentially issuable shares Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Number of shares issued for intangible assets Value of shares issued for intangible assets Advances payable to third party Total convertible notes payable Less: current portion of convertible notes payable Less: discount on noncurrent convertible notes payable Long-term convertible notes payable, net of discount Current portion of convertible notes payable Discount on current convertible notes payable Long-term convertible notes payable, net of discount Issuance date Debt instrument, face amount Conversion price (in dollars per share) Percentage of debt discount Maximum percentage of the outstanding stock of the company upto which holder of the notes can convert the notes into shares of common stock Accrued interest Number of shares issued Refers to amount of advance payble incurred during the period. Disclosure of advance payble to related party. It refers to the name of an entity. Refers to the amount of conversion of accrued interest into common stock. Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder. Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder. Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder. Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder. Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder. Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder. Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder. Information about convertible notes payable. Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder. Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Gross Convertible Notes Payable. Gross Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. Amount of accrued, but unpaid interest on the debt instrument for the period. Amount of debt discount related to debt instrument. The amount of debt discount on noncurrent portion of debt that was originally recognized at the issuance of the instrument that has yet to be amortized. Refers the amount of depletion and accretion during the reporting period. Information about legal entity. Refers to change in estimated of asset retire obligation. The maximum percentage of the outstanding stock of the Company upto which holder of the notes can convert the notes into shares of common stock. Information about the minns project. Impairment of oil and gas property carried under the full cost method. Refers to percentage of revenue during the period related to oil and gas business activities. Information about the operator one. Information about the operator two. Information about the participation agreement. The cash outflow percentage for exploration and development of oil and gas properties. It includes cash payments related to development of oil and gas wells drilled at previously untested geologic structures (to determine the presence of oil or gas) and wells drilled at sites where the presence of oil or gas has already been established (to extract the oil or gas). Refers to percentage of reduction in working interest in agreement. Refers to percentage of working interest in agreement. Refers to projected drilling feet under the agreement. Proved oil and gas properties, net of depletion, carried under the full cost method. Date of convertible note payable was made available and submitted, in CCYY-MM-DD format. Date of convertible note payable was made available and submitted, in CCYY-MM-DD format. Date of convertible note payable was made available and submitted, in CCYY-MM-DD format. Date of convertible note payable was made available and submitted, in CCYY-MM-DD format. Date of convertible note payable was made available and submitted, in CCYY-MM-DD format. Date of convertible note payable was made available and submitted, in CCYY-MM-DD format. Unproved oil and gas properties, net of depletion, carried under the full cost method. Information about legal entity. Aggregate par or stated value of issued nonredeemable preferred stock Series E (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. Total number of nonredeemable preferred Shares Series E (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Aggregate share number for all nonredeemable preferred stock Series E (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Total number of nonredeemable preferred Shares Series A (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Aggregate share number for all nonredeemable preferred stock Series A (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Aggregate par or stated value of issued nonredeemable preferred stock Series A (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. Assets, Current Oil and Gas Property, Full Cost Method, Net Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Interest Expense Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Interest Payable, Net Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash and Cash Equivalents, Period Increase (Decrease) Fair Value of Assets Acquired Capitalized Costs of Unproved Properties Excluded from Amortization, Period Cost Acquisition Costs, Cumulative Development Costs, Cumulative Exploration Costs, Cumulative Capitalized Costs of Unproved Properties Excluded from Amortization, Cumulative ConvertibleNotesPayable10Member ConvertibleNotesPayable8Member ReportDate1Member ReportDate2Member ReportDate3Member ReportDate4Member ReportDate5Member ReportDate6Member EX-101.PRE 8 soan-20160630_pre.xml XBRL PRESENTATION FILE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
Document and Entity Information - shares
2 Months Ended
Jun. 30, 2016
Sep. 13, 2016
Document And Entity Information    
Entity Registrant Name AngioSoma, Inc.  
Entity Central Index Key 0001502152  
Document Type 10-Q  
Trading Symbol SOAN  
Document Period End Date Jun. 30, 2016  
Amendment Flag false  
Current Fiscal Year End Date --09-30  
Entity a Well-known Seasoned Issuer No  
Entity a Voluntary Filer No  
Entity's Reporting Status Current Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   31,520,667
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2016  
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
Jun. 30, 2016
USD ($)
CURRENT ASSETS  
Cash and cash equivalents $ 8,789
Accounts receivable and accrued revenue receivable 4,440
Prepaid expenses 1,250
Total current assets 14,479
Intellectual property 2,990,535
Available for sale securities, full cost method of accounting: 13,002
Oil and gas properties  
Evaluated property, net of accumulated depletion of $116,673 and net of accumulated impairment of $128,358 33,742
Unevaluated property 200,575
Total oil and gas properties 234,317
TOTAL ASSETS 3,252,333
CURRENT LIABILITIES  
Accounts payable and accrued liabilities 143,188
Accounts payable to related party 15,577
Advances payable 21,650
Advances payable to related party 11,000
Current portion of convertible notes payable, net of discount of $143,438 369,055
Short term notes payable 35,000
Current portion of accrued interest payable 52,137
Current portion of asset retirement obligation 15,000
Total current liabilities 662,607
Convertible notes payable, net of discount of $376,773 20,441
Accrued interest payable 23,946
Asset retirement obligation 6,116
TOTAL LIABILITIES 713,110
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY (DEFICIT)  
Common stock, $0.0010 par value; 480,000,000 shares authorized; 31,520,667 shares issued and outstanding at June 30, 2016 31,521
Preferred stock; $0.001 par value; 20,000,000 shares authorized  
Series A Preferred stock; 5,000,000 shares issued and outstanding 2,990,535
Series E Preferred stock; 1,000,000 shares issued and outstanding 1,000
Additional paid-in capital (395,451)
Accumulated other comprehensive income (4,464)
Accumulated deficit (83,918)
Total stockholders' equity (deficit) 2,539,223
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 3,252,333
XML 11 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)
Jun. 30, 2016
USD ($)
$ / shares
shares
Statement of Financial Position [Abstract]  
Evaluated property, accumulated depletion | $ $ 116,673
Evaluated property, accumulated impairment | $ 128,358
Current portion of convertible notes payable, discount | $ 143,438
Noncurrent portion of convertible notes payable, discount | $ $ 376,773
Common stock, par value (in dollars per share) | $ / shares $ 0.0010
Common stock, authorized 480,000,000
Common stock, issued 31,520,667
Common stock, outstanding 31,520,667
Preferred stock, par value (in dollars per share) | $ / shares $ 0.001
Preferred stock, authorized 20,000,000
Series A Preferred stock, issued 5,000,000
Series A Preferred stock, outstanding 5,000,000
Series E Preferred stock, issued 1,000,000
Series E Preferred stock, outstanding 1,000,000
XML 12 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
2 Months Ended
Jun. 30, 2016
USD ($)
$ / shares
shares
Income Statement [Abstract]  
OIL AND GAS SALES, net $ 1,665
OPERATING EXPENSES  
Lease operating expense 108
Depletion, depreciation and amortization 386
Accretion expense 121
General and administrative expenses 25,292
Total operating expenses 25,907
LOSS FROM OPERATIONS (24,242)
OTHER INCOME (EXPENSE)  
Interest expense (59,676)
NET LOSS $ (83,918)
NET LOSS PER COMMON SHARE - Basic and diluted (in dollars per share) | $ / shares $ (0.00)
COMMON SHARES OUTSTANDING - Basic and diluted (in shares) | shares 18,780,547
XML 13 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
2 Months Ended
Jun. 30, 2016
USD ($)
Consolidated Statements Of Comprehensive Income  
NET LOSS $ (83,918)
Change in fair value of available-for-sale securities (4,464)
Comprehensive loss $ (88,382)
XML 14 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - 2 months ended Jun. 30, 2016 - USD ($)
Common Stock [Member]
Series A Preferred Stock [Member]
Series E Preferred Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Total
BALANCE AT BEGINING at Apr. 29, 2016 $ 10,023 $ 1,000 $ 11,023
BALANCE AT BEGINING (in shares) at Apr. 29, 2016 10,022,543   1,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (83,918) (83,918)
Other comprehensive loss (4,464) (4,464)
Common stock issued for conversion of convertible note payable $ 1,498 5,993 7,491
Common stock issued for conversion of convertible note payable (in shares) 1,498,124            
Common stock issued for acquisition $ 20,000 (401,444) (381,444)
Common stock issued for acquisition (in shares) 20,000,000            
Preferred stock issued for intellectual property $ 2,990,535 2,990,535
Preferred stock issued for intellectual property (in shares)   5,000,000          
BALANCE AT END at Jun. 30, 2016 $ 31,521     $ (395,451) $ (4,464) $ (83,918) $ 2,539,223
BALANCE AT END (in shares) at Jun. 30, 2016 31,520,667 5,000,000 1,000,000        
XML 15 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
2 Months Ended
Jun. 30, 2016
USD ($)
shares
CASH FLOW FROM OPERATING ACTIVITIES:  
Net loss $ (83,918)
Adjustments to reconcile net loss to net cash used in operating activities:  
Depletion and accretion 507
Amortization of discount on convertible note payable 52,034
Changes in operating assets and liabilities:  
Accounts receivable and accrued revenue (404)
Accounts payable and accrued liabilities 12,138
Accrued interest payable 7,642
NET CASH USED IN OPERATING ACTIVITIES (12,001)
CASH FLOWS FROM INVESTING ACTIVITIES  
Net cash received on acquisition of First Titan Corp. 5,690
NET CASH USED IN INVESTING ACTIVITIES 5,690
CASH FLOWS FROM FINANCING ACTIVITIES  
Proceeds from advances 15,100
NET CASH PROVIDED BY FINANCING ACTIVITIES 15,100
NET INCREASE (DECREASE) IN CASH 8,789
CASH, at the beginning of the period
CASH, at the end of the period 8,789
Cash paid during the period for:  
Interest
Taxes
Noncash investing and financing transaction:  
Change in asset retirement obligation 75
Conversion of accrued interest into common stock $ 7,491
Intellectual property acquired with Series A Preferred Stock | shares 2,990,535
Common stock and preferred stock issued for reverse acquisition $ 480,921
Change in fair value of available-for-sale securities $ (4,464)
XML 16 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
General Organization and Business
2 Months Ended
Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
General Organization and Business

Note 1. General Organization and Business

 

AngioSoma Inc., a Nevada corporation, is a clinical stage biotechnology company focused on improving the effectiveness of current standard-of-care treatments, especially related to endovascular interventions in the treatment of peripheral artery disease (PAD).

 

AngioSoma Nevada is developing its lead product, a drug candidate called LiprostinTM for the treatment of peripheral artery disease, or PAD, which has completed FDA Phase I and three Phase II clinical trials. We are in discussions with several contract research organizations for completion of our FDA protocol for Phase III and submission of our new drug application for marketing in the US and its territories.

 

The Company incorporated on April 29, 2016. The Company’s year-end is September 30.

 

On June 3, 2016, we entered into a business combination whereby a wholly-owned subsidiary of the Company, AngioSoma Research, Inc., a Texas corporation, (“AngioSoma Texas”) merged with AngioSoma Research, Inc., a Nevada corporation, (“AngioSoma Nevada”) with AngioSoma Research Texas surviving as our wholly-owned subsidiary (the “Merger”) . In connection with the Merger, the Company issued to the holders of outstanding common stock of AngioSoma Nevada 20 million shares of the Company’s common stock (“Common Stock”) and, as a result, immediately following the completion of the Merger, the former equity holders of AngioSoma Nevada owned approximately 66% of the Common Stock and the stockholders of First Titan Corp. immediately prior to the Merger owned approximately 34% of the Common Stock, in each case, on a fully-diluted basis (subject to certain exceptions and adjustments).  Also in connection with the Merger, the pre-Merger director and officer of the Company tendered his resignation and the pre-Merger director and officer of AngioSoma Nevada was appointed as the new director and officer of the Company, and our corporate headquarters was moved from Las Vegas, Nevada to Montgomery, Texas. In connection with completion of the Merger, the Company changed its corporate name from First Titan Corp. to AngioSoma, Inc. and its common stock continues to trade on the OTC Markets Group, OTCQB tier under the new trading symbol “SOAN”.

 

First Titan Energy’s oil and gas development activities include the following:

 

Alabama – On May 2, 2012, we acquired a one percent working interest in one well in Little Cedar Creek Field in Alabama. This well was drilled during the fiscal year ended September 30, 2012 and we began receiving revenue during the fiscal year ended September 30, 2013. This well is located in the Little Cedar Field, Alabama’s largest producing oil field. This well is currently producing oil and natural gas from one well.

 

Louisiana – On January 3, 2012, we entered into a participation agreement in an oil and gas drilling project in Calcasieu Parish, Louisiana (the “Participation Agreement”). The South Lake Charles Prospect is located seven miles south of the city of Lake Charles, Louisiana. It is a middle Oligocene age geo-pressured prospect located in the middle and lower hackberry sands. Under the terms of the Participation Agreement, we will participate in the drilling of one well and may participate in the drilling of future wells if it chooses. We will pay 25% of the drilling cost of the first well and will receive 13.59% of the net revenue from the well. We anticipate that our share of the total drilling and completion cost of the initial well, projected to be drilled to approximately 15,500 feet, will be $3.4 million. On August 12, 2013, the Participation Agreement was amended to reduce our working interest to 1.8%. As a result, our share of the drilling cost is expected to be approximately $181,000. The Company has paid $143,264 of its share of the costs of the well to date. We will receive 1.4% of the revenue from this well. The well began being drilled during the year ended September 30, 2014. During the year ended September 30, 2015, before the completion of the well, the well was damaged by a subcontractor working on the well. The operator of the well is in arbitration with the relevant subcontractors for compensation on the damage to the well.

 

Texas – On July 7, 2013, the Company acquired a 30% working interest in the Minns Project located in Waller County, Texas. The project included three producing wells and a salt water disposal well within the Brookshire Field. This well was reworked and deepened during the year ended September 30, 2014. It is currently producing oil from one well.

XML 17 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Going Concern
2 Months Ended
Jun. 30, 2016
Accounting Policies [Abstract]  
Going Concern

Note 2. Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. For the period from inception (April 29, 2016) through June 30, 2016, the Company had a net loss of $83,918 and negative cash flow from operating activities of $12,001. As of June 30, 2016, the Company had negative working capital of $648,128. Management does not anticipate having positive cash flow from operations in the near future.

 

These factors raise a substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business.

 

Management has plans to address the Company’s financial situation as follows:

 

In the near term, management plans to continue to focus on raising the funds necessary to implement the Company’s business plan. Management will continue to seek out debt financing to obtain the capital required to meet the Company’s financial obligations. There is no assurance, however, that lenders will continue to advance capital to the Company or that the new business operations will be profitable. The possibility of failure in obtaining additional funding and the potential inability to achieve profitability raise doubts about the Company’s ability to continue as a going concern.

 

In the long term, management believes that the Company’s projects and initiatives will be successful and will provide cash flow to the Company, which will be used to finance the Company’s future growth. However, there can be no assurances that the Company’s planned activities will be successful, or that the Company will ultimately attain profitability. The Company’s long-term viability depends on its ability to obtain adequate sources of debt or equity funding to meet current commitments and fund the continuation of its business operations, and the ability of the Company to achieve adequate profitability and cash flows from operations to sustain its operations.

XML 18 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies
2 Months Ended
Jun. 30, 2016
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 3. Summary of Significant Accounting Policies

 

Interim Financial Statements

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. The results of operations for the period from inception (April 29, 2016) through June 30, 2016 are not necessarily indicative of the results to be expected for the full fiscal year ending September 30, 2016.

 

Consolidated Financial Statements

 

The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, AngioSoma Research, LLC, First Titan Energy, LLC and First Titan Technical, LLC from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Credit Risk due to Certain Concentrations

 

We extend credit, primarily in the form of uncollateralized oil and gas sales through the operators of our working interests, to various companies in the oil and gas industry, which results in a concentration of credit risk. The concentration of credit risk may be affected by changes in economic or other conditions within our industry and may accordingly affect our overall credit risk. However, we believe that the risk of these unsecured receivables is mitigated by the nature of the companies to which we extend credit. For the period from inception (April 29, 2016) through June 30, 2016, two operators accounted for 54% and 46% of our oil and gas sales. Those operators account for 35% and 65% of accounts receivable as of June 30, 2016. We did not recognize any credit losses during the period from inception (April 29, 2016) through June 30, 2016. We have not recognized an allowance for doubtful accounts as of June 30, 2016.

 

Oil and Gas Properties

 

The Company follows the full cost method of accounting for its oil and gas properties, whereby all costs incurred in connection with the acquisition, exploration for and development of petroleum and natural gas reserves are capitalized. Such costs include lease acquisition, geological and geophysical activities, rentals on non-producing leases, drilling, completing, and equipping of oil and gas wells and administrative costs directly attributable to those activities and asset retirement costs. Disposition of oil and gas properties are accounted for as a reduction of capitalized costs, with no gain or loss recognized unless such adjustment would significantly alter the relationship between capital costs and proved reserves of oil, in which case the gain or loss is recognized in the statement of operations.

 

Depletion of capitalized oil and gas properties and estimated future development costs, excluding unproved properties, are based on the units-of-production method based on proved reserves. The company recognized $386 of depletion during the period from inception (April 29, 2016) through June 30, 2016. Net capitalized costs of oil and gas properties, less related deferred taxes, are limited to the lower of unamortized cost or the cost ceiling, defined as the sum of the present value of estimated future net revenues from proved reserves based on unescalated prices discounted at ten percent, plus the cost of properties not being amortized, if any, plus the lower of cost or estimated fair value of unproved properties included in the costs being amortized, if any, less related income taxes. As of June 30, 2016, the Company has oil and gas properties in the amount of $200,575, which are being excluded from amortization because they have not been evaluated to determine whether proved reserves are associated with those properties. Costs in excess of the present value of estimated future net revenues as discussed above are charged to impairment expense. The Company applies the full cost-ceiling test on a quarterly basis on the date of the latest balance sheet presented.

 

Based on management’s review, 100% of the unproved oil and gas properties balance as of June 30, 2016 are expected to be added to amortization during the year ending September 30, 2016. The table below sets forth the cost of unproved properties excluded from the amortization base as of June 30, 2016 and notes the year in which the associated costs were incurred:

 

    Year of Acquisition      
    2012   2013   2014   2015   Total  
Acquisition costs   $ 153,264   $ 47,311   $   $   $ 200,575  
Development costs                      
Exploration costs                      
Total   $ 153,264   $ 47,311   $   $   $ 200,575  

 

Asset retirement costs are recognized when the asset is placed in service, and are included in the amortization base and amortized over proved reserves using the units of production method. Asset retirement costs are estimated by management using existing regulatory requirements and anticipated future inflation rates.

 

Financial Instruments

 

The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period between the origination of these instruments and their expected realization.

 

FASB Accounting Standards Codification (ASC) 820 Fair Value Measurements and Disclosures (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

   
Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
   
Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
   
Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of June 30, 2016. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, other current assets, accounts payable, and accrued expenses. The fair value of the Company’s notes payable is estimated based on current rates that would be available for debt of similar terms that is not significantly different from its stated value.

 

The following table presents assets that were measured and recognized at fair value as of June 30, 2016 and the period then ended on a recurring and nonrecurring basis:

 

June 30, 2016

 

Description

  Level 1   Level 2   Level 3   Total Realized Loss
Asset retirement obligation   $   $   $ 21,116   $
Available for sale securities     13,002            
Totals   $ 13,002   $   $ 21,116   $

 

Revenue Recognition

 

Sales of crude oil are recognized when the delivery to the purchaser has occurred and title has been transferred. This occurs when oil has been delivered to a pipeline or a tank lifting has occurred. Crude oil is priced on the delivery date based upon prevailing prices published by purchasers with certain adjustments related to oil quality and physical location.

 

Common Stock

 

The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.

 

Income Taxes

 

The Company accounts for income taxes under ASC 740 Income Taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. No deferred tax assets or liabilities were recognized as of June 30, 2016.

 

Earnings (Loss) per Common Share

 

The Company computes basic and diluted earnings per common share amounts in accordance with ASC Topic 260, Earnings per Share. The basic earnings (loss) per common share are calculated by dividing the Company’s net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.

 

In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation. The Company’s convertible debt is considered anti-dilutive due to the Company’s net loss for the period from inception (April 29, 2016) through June30, 2016. As a result, the Company did not have any potentially dilutive common shares for that period. At June 30, 2016, the Company had 32,762,153 potentially issuable shares upon the conversion of convertible notes payable and interest.

 

Beneficial Conversion Feature

 

Beneficial conversion feature is a non-detachable conversion feature that is in the money at the commitment date. The Company follows the guidance of ASC Subtopic 470-20 Debt with Conversion and Other Options to evaluate as to whether beneficial conversion feature exists. Pursuant to Section 470-20-30 an embedded beneficial conversion feature recognized separately under paragraph 470-20-25-5 shall be measured initially at its intrinsic value at the commitment date (see paragraphs 470-20-30-9 through 30-12) as the difference between the conversion price (see paragraph 470-20-30-5) and the fair value of the common stock or other securities into which the security is convertible, multiplied by the number of shares into which the security is convertible. When the Company issues a debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company’s common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.

 

Commitments and Contingencies

 

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. There are no known commitments or contingencies as of June 30, 2016.

 

Recently Issued Accounting Pronouncements

 

We have reviewed the FASB issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation’s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.

 

Subsequent events

 

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR..

XML 19 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Acquisition
2 Months Ended
Jun. 30, 2016
Business Combinations [Abstract]  
Acquisition

Note 4. Acquisition

 

On June 3, 2016, we entered into a business combination whereby a wholly-owned subsidiary of the Company, AngioSoma Research, Inc., a Texas corporation, (“AngioSoma Texas”) merged with AngioSoma Research, Inc., a Nevada corporation, (“AngioSoma Nevada”) with AngioSoma Research Texas surviving as our wholly-owned subsidiary (the “Merger”) . In connection with the Merger, the Company issued to the holders of outstanding common stock of AngioSoma Nevada 20 million shares of the Company’s common stock (“Common Stock”) and, as a result, immediately following the completion of the Merger, the former equity holders of AngioSoma Nevada owned approximately 66% of the Common Stock and the stockholders of First Titan Corp. immediately prior to the Merger owned approximately 34% of the Common Stock, in each case, on a fully-diluted basis (subject to certain exceptions and adjustments).  Also in connection with the Merger, the pre-Merger director and officer of the Company tendered his resignation and the pre-Merger director and officer of AngioSoma Nevada was appointed as the new director and officer of the Company, and our corporate headquarters was moved from Las Vegas, Nevada to Montgomery, Texas. In connection with completion of the Merger, the Company changed its corporate name from First Titan Corp. to AngioSoma, Inc. and its common stock continues to trade on the OTC Markets Group, OTCQB tier under the new trading symbol “SOAN”.

 

For accounting purposes, the Merger is treated as a “reverse acquisition” under generally acceptable accounting principles in the United States (“U.S. GAAP”) and AngioSoma Nevada is considered the accounting acquirer. Accordingly, AngioSoma’s historical results of operations will replace the Company’s historical results of operations for all periods prior to the Merger and, for all periods following the Merger, the results of operations of the combined company will be included in the Company’s financial statements.

XML 20 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Intellectual Property
2 Months Ended
Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Intellectual Property

Note 5. Intellectual Property

 

On April 29, 2016, an individual contributed certain medical intellectual property to the Company in exchange for 5,000,000 shares of Series A Preferred Stock. The transaction was valued at $2,990,535 based upon the value of the Series A Preferred Stock as determined by a valuation expert.

XML 21 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
Advances Payable to Related Party
2 Months Ended
Jun. 30, 2016
Debt Disclosure [Abstract]  
Advances Payable to Related Party

Note 6. Advances Payable to Related Party

 

During the period from inception (April 29, 2016) through June 30, 2016, the Company received non-interest bearing advances from a shareholder of the Company in the amount of $11,000. The advances remained outstanding as of June 30, 2016.

XML 22 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
Advances
2 Months Ended
Jun. 30, 2016
Debt Disclosure [Abstract]  
Advances

Note 7. Advances

 

As of June 30, 2016, the Company had non-interest bearing advances payable to a third party of $21,650. These advances are payable on demand.

XML 23 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
Convertible Notes Payable
2 Months Ended
Jun. 30, 2016
Debt Disclosure [Abstract]  
Convertible Notes Payable

Note 8. Convertible Notes Payable

 

Convertible notes payable consisted of the following at June 30, 2016:

 

Convertible note dated September 30, 2013 in the original principal amount of $528,434, maturing September 30, 2015, bearing interest at 10% per year, convertible into common stock at a rate of $0.04 per share, in default.   $ 2,324  
Convertible note dated June 30, 2014 payable in the original principal amount of $276,825, maturing June 30, 2016, bearing interest at 10% per year, convertible into common stock at a rate of $0.03 per share.     276,285  
Convertible note dated December 31, 2014 in the original principal amount of $118,620, maturing December 31, 2016, bearing interest at 10% per year, convertible into common stock at a rate of $0.01 per share.     118,620  
Convertible note dated March 31, 2015 in the original principal amount of $49,190, maturing March 31, 2017, bearing interest at 10% per year, convertible into common stock at a rate of $0.005 per share     49,190  
Convertible note dated June 30, 2015 in the original principal amount of $66,074, maturing June 30, 2017, bearing interest at 10% per year, convertible into common stock at a rate of $0.53 per share     66,074  
Convertible note dated September 30, 2015 in the original principal amount of $235,313, maturing September 30, 2018, bearing interest at 10% per year, convertible into common stock a rate of $0.75 per share     235,313  
Convertible note dated December 31, 2015 in the original principal amount of $90,040, maturing December 31, 2018, bearing interest at 10% per year, convertible into common stock at a rate of $0.08 per share     90,040  
Convertible note dated March 31, 2016 in the original principal amount of $71,861, maturing March 31, 2019, bearing interest at 10% per year, convertible into common stock at a rate of a 60% discount to the market price on the date of conversion     71,861  
Total convertible notes payable   $ 909,707  
         
Less: current portion of convertible notes payable     (512,493 )
Less: discount on noncurrent convertible notes payable     (376,773 )
Long-term convertible notes payable, net of discount   $ 20,441  
         
Current portion of convertible notes payable     512,493  
Discount on current convertible notes payable     (143,438 )
Long-term convertible notes payable, net of discount   $ 369,055  

 

All principal along with accrued interest is payable on the maturity date. The notes are convertible into common stock at the option of the holder. The holder of the notes cannot convert the notes into shares of common stock if that conversion would result in the holder owning more than 4.9% of the outstanding stock of the Company.

 

Conversions to Common Stock

 

During period from inception (April 29, 2016) through June 30, 2016, the holders of the Convertible Note Payable dated December 31, 2014 elected to convert accrued interest of $7,491 into 1,498,124 shares of common stock. No gain or loss was recognized on the conversions as they occurred within the terms of the agreement that provided for conversion.

XML 24 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stockholders' Equity
2 Months Ended
Jun. 30, 2016
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

Note 9. Stockholders’ Equity

 

Common stock issued for reverse acquisition

 

On June 3, 2016, the Company issued 20,000,000 shares for the reverse acquisition of AngioSoma Nevada. See Note 4.

 

Common stock issued for conversion of convertible note payable

 

On June 28, 2016, the Company issued 1,498,124 shares of common stock upon the conversion of accrued interest of $7,491. No gain or loss was recognized on the transaction because it was transacted within the terms of the convertible note payable.

 

Series A Preferred Stock

 

On April 29, 2016, an individual contributed certain medical intellectual property to the Company in exchange for 5,000,000 shares of Series A Preferred Stock. The transaction was valued at $2,990,535 based upon the value of the Series A Preferred Stock as determined by a valuation expert.

XML 25 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
Subsequent Events
2 Months Ended
Jun. 30, 2016
Subsequent Events [Abstract]  
Subsequent Events

Note 10. Subsequent Events

 

The Company has reviewed subsequent events through the filing of this report and has noted none that require disclosure.

XML 26 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies (Policies)
2 Months Ended
Jun. 30, 2016
Accounting Policies [Abstract]  
Interim Financial Statements

Interim Financial Statements

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. The results of operations for the period from inception (April 29, 2016) through June 30, 2016 are not necessarily indicative of the results to be expected for the full fiscal year ending September 30, 2016.

Consolidated Financial Statements

Consolidated Financial Statements

 

The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries, AngioSoma Research, LLC, First Titan Energy, LLC and First Titan Technical, LLC from the date of their formations or acquisition. Significant intercompany transactions have been eliminated in consolidation.

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Credit Risk due to Certain Concentrations

Credit Risk due to Certain Concentrations

 

We extend credit, primarily in the form of uncollateralized oil and gas sales through the operators of our working interests, to various companies in the oil and gas industry, which results in a concentration of credit risk. The concentration of credit risk may be affected by changes in economic or other conditions within our industry and may accordingly affect our overall credit risk. However, we believe that the risk of these unsecured receivables is mitigated by the nature of the companies to which we extend credit. For the period from inception (April 29, 2016) through June 30, 2016, two operators accounted for 54% and 46% of our oil and gas sales. Those operators account for 35% and 65% of accounts receivable as of June 30, 2016. We did not recognize any credit losses during the period from inception (April 29, 2016) through June 30, 2016. We have not recognized an allowance for doubtful accounts as of June 30, 2016.

Oil and Gas Properties

Oil and Gas Properties

 

The Company follows the full cost method of accounting for its oil and gas properties, whereby all costs incurred in connection with the acquisition, exploration for and development of petroleum and natural gas reserves are capitalized. Such costs include lease acquisition, geological and geophysical activities, rentals on non-producing leases, drilling, completing, and equipping of oil and gas wells and administrative costs directly attributable to those activities and asset retirement costs. Disposition of oil and gas properties are accounted for as a reduction of capitalized costs, with no gain or loss recognized unless such adjustment would significantly alter the relationship between capital costs and proved reserves of oil, in which case the gain or loss is recognized in the statement of operations.

 

Depletion of capitalized oil and gas properties and estimated future development costs, excluding unproved properties, are based on the units-of-production method based on proved reserves. The company recognized $386 of depletion during the period from inception (April 29, 2016) through June 30, 2016. Net capitalized costs of oil and gas properties, less related deferred taxes, are limited to the lower of unamortized cost or the cost ceiling, defined as the sum of the present value of estimated future net revenues from proved reserves based on unescalated prices discounted at ten percent, plus the cost of properties not being amortized, if any, plus the lower of cost or estimated fair value of unproved properties included in the costs being amortized, if any, less related income taxes. As of June 30, 2016, the Company has oil and gas properties in the amount of $200,575, which are being excluded from amortization because they have not been evaluated to determine whether proved reserves are associated with those properties. Costs in excess of the present value of estimated future net revenues as discussed above are charged to impairment expense. The Company applies the full cost-ceiling test on a quarterly basis on the date of the latest balance sheet presented.

 

Based on management’s review, 100% of the unproved oil and gas properties balance as of June 30, 2016 are expected to be added to amortization during the year ending September 30, 2016. The table below sets forth the cost of unproved properties excluded from the amortization base as of June 30, 2016 and notes the year in which the associated costs were incurred:

 

    Year of Acquisition      
    2012   2013   2014   2015   Total  
Acquisition costs   $ 153,264   $ 47,311   $   $   $ 200,575  
Development costs                      
Exploration costs                      
Total   $ 153,264   $ 47,311   $   $   $ 200,575  

 

Asset retirement costs are recognized when the asset is placed in service, and are included in the amortization base and amortized over proved reserves using the units of production method. Asset retirement costs are estimated by management using existing regulatory requirements and anticipated future inflation rates.

Financial Instruments

Financial Instruments

 

The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period between the origination of these instruments and their expected realization.

 

FASB Accounting Standards Codification (ASC) 820 Fair Value Measurements and Disclosures (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

 

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
   
Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
   
Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of June 30, 2016. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, other current assets, accounts payable, and accrued expenses. The fair value of the Company’s notes payable is estimated based on current rates that would be available for debt of similar terms that is not significantly different from its stated value.

 

The following table presents assets that were measured and recognized at fair value as of June 30, 2016 and the period then ended on a recurring and nonrecurring basis:

 

June 30, 2016

 

Description

  Level 1   Level 2   Level 3   Total Realized Loss
Asset retirement obligation   $   $   $ 21,116   $
Available for sale securities     13,002            
Totals   $ 13,002   $   $ 21,116   $
Revenue Recognition

Revenue Recognition

 

Sales of crude oil are recognized when the delivery to the purchaser has occurred and title has been transferred. This occurs when oil has been delivered to a pipeline or a tank lifting has occurred. Crude oil is priced on the delivery date based upon prevailing prices published by purchasers with certain adjustments related to oil quality and physical location.

Common Stock

Common Stock

 

The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.

Income Taxes

Income Taxes

 

The Company accounts for income taxes under ASC 740 Income Taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. No deferred tax assets or liabilities were recognized as of June 30, 2016.

Earnings (Loss) per Common Share

Earnings (Loss) per Common Share

 

The Company computes basic and diluted earnings per common share amounts in accordance with ASC Topic 260, Earnings per Share. The basic earnings (loss) per common share are calculated by dividing the Company’s net income available to common shareholders by the weighted average number of common shares outstanding during the year. The diluted earnings (loss) per common share are calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted as of the first of the year for any potentially dilutive debt or equity. There are no dilutive shares outstanding for any periods reported.

 

In periods in which a net loss has been incurred, all potentially dilutive common shares are considered anti-dilutive and thus are excluded from the calculation. The Company’s convertible debt is considered anti-dilutive due to the Company’s net loss for the period from inception (April 29, 2016) through June30, 2016. As a result, the Company did not have any potentially dilutive common shares for that period. At June 30, 2016, the Company had 32,762,153 potentially issuable shares upon the conversion of convertible notes payable and interest.

Beneficial Conversion Feature

Beneficial Conversion Feature

 

Beneficial conversion feature is a non-detachable conversion feature that is in the money at the commitment date. The Company follows the guidance of ASC Subtopic 470-20 Debt with Conversion and Other Options to evaluate as to whether beneficial conversion feature exists. Pursuant to Section 470-20-30 an embedded beneficial conversion feature recognized separately under paragraph 470-20-25-5 shall be measured initially at its intrinsic value at the commitment date (see paragraphs 470-20-30-9 through 30-12) as the difference between the conversion price (see paragraph 470-20-30-5) and the fair value of the common stock or other securities into which the security is convertible, multiplied by the number of shares into which the security is convertible. When the Company issues a debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company’s common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.

Commitments and Contingencies

Commitments and Contingencies

 

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. There are no known commitments or contingencies as of June 30, 2016.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

We have reviewed the FASB issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation’s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.

Subsequent events

Subsequent events

 

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements were issued. Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

XML 27 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies (Tables)
2 Months Ended
Jun. 30, 2016
Accounting Policies [Abstract]  
Schedule of cost of unproved properties excluded from the amortization base

The table below sets forth the cost of unproved properties excluded from the amortization base as of June 30, 2016 and notes the year in which the associated costs were incurred:

 

    Year of Acquisition      
    2012   2013   2014   2015   Total  
Acquisition costs   $ 153,264   $ 47,311   $   $   $ 200,575  
Development costs                      
Exploration costs                      
Total   $ 153,264   $ 47,311   $   $   $ 200,575  
Schedule of assets measured and recognized at fair value on a recurring and nonrecurring basis

The following table presents assets that were measured and recognized at fair value as of June 30, 2016 and the period then ended on a recurring and nonrecurring basis:

 

June 30, 2016

 

Description

  Level 1   Level 2   Level 3   Total Realized Loss
Asset retirement obligation   $   $   $ 21,116   $
Available for sale securities     13,002            
Totals   $ 13,002   $   $ 21,116   $
XML 28 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
Convertible Notes Payable (Tables)
2 Months Ended
Jun. 30, 2016
Debt Disclosure [Abstract]  
Schedule of convertible notes payable

Convertible notes payable consisted of the following at June 30, 2016:

 

Convertible note dated September 30, 2013 in the original principal amount of $528,434, maturing September 30, 2015, bearing interest at 10% per year, convertible into common stock at a rate of $0.04 per share, in default.   $ 2,324  
Convertible note dated June 30, 2014 payable in the original principal amount of $276,825, maturing June 30, 2016, bearing interest at 10% per year, convertible into common stock at a rate of $0.03 per share.     276,285  
Convertible note dated December 31, 2014 in the original principal amount of $118,620, maturing December 31, 2016, bearing interest at 10% per year, convertible into common stock at a rate of $0.01 per share.     118,620  
Convertible note dated March 31, 2015 in the original principal amount of $49,190, maturing March 31, 2017, bearing interest at 10% per year, convertible into common stock at a rate of $0.005 per share     49,190  
Convertible note dated June 30, 2015 in the original principal amount of $66,074, maturing June 30, 2017, bearing interest at 10% per year, convertible into common stock at a rate of $0.53 per share     66,074  
Convertible note dated September 30, 2015 in the original principal amount of $235,313, maturing September 30, 2018, bearing interest at 10% per year, convertible into common stock a rate of $0.75 per share     235,313  
Convertible note dated December 31, 2015 in the original principal amount of $90,040, maturing December 31, 2018, bearing interest at 10% per year, convertible into common stock at a rate of $0.08 per share     90,040  
Convertible note dated March 31, 2016 in the original principal amount of $71,861, maturing March 31, 2019, bearing interest at 10% per year, convertible into common stock at a rate of a 60% discount to the market price on the date of conversion     71,861  
Total convertible notes payable   $ 909,707  
         
Less: current portion of convertible notes payable     (512,493 )
Less: discount on noncurrent convertible notes payable     (376,773 )
Long-term convertible notes payable, net of discount   $ 20,441  
         
Current portion of convertible notes payable     512,493  
Discount on current convertible notes payable     (143,438 )
Long-term convertible notes payable, net of discount   $ 369,055  
XML 29 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
General Organization and Business (Details Narrative)
2 Months Ended
Jun. 03, 2016
USD ($)
Aug. 12, 2013
USD ($)
Jul. 07, 2013
Number
Jan. 03, 2012
USD ($)
ft²
Number
Jun. 30, 2016
USD ($)
Number of common shares issued for aquisition         $ (381,444)
First Titan Corp [Member]          
Percentage of common stock owned 34.00%        
AngioSoma Research Nevada [Member]          
Number of common shares issued for aquisition $ 20,000,000        
Percentage of common stock owned 66.00%        
Waller County, Texas [Member] | Minns Project [Member]          
Number of wells in processs fo drilling | Number     3    
Percentage of working interest     30.00%    
Participation Agreement [Member] | Calcasieu Parish, Louisiana [Member]          
Number of wells in processs fo drilling | Number       1  
Percentage of oil and gas production expense       25.00%  
Percentage of oil and gas revenue   1.40%   13.59%  
Projected drilling feet | ft²       15,500  
Total drilling and completion cost   $ 181,000   $ 3,400,000  
Percentage of reduce working interest   1.80%      
Payment of oil and gas cost   $ 143,264      
XML 30 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Going Concern (Details Narrative)
2 Months Ended
Jun. 30, 2016
USD ($)
Accounting Policies [Abstract]  
Net loss $ (83,918)
Cash flow from operating activities (12,001)
Working capital $ (648,128)
XML 31 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies (Details) - USD ($)
12 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2012
Jun. 30, 2016
Cost of unproved properties excluded from amortization, period costs:          
Acquisition costs $ 47,311 $ 153,264  
Development costs  
Exploration costs  
Total $ 47,311 $ 153,264  
Cost of unproved properties excluded from amortization, cumulative costs:          
Acquisition costs         $ 200,575
Development costs        
Exploration costs        
Total         $ 200,575
XML 32 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies (Details 1)
2 Months Ended
Jun. 30, 2016
USD ($)
Total Realized Loss
Asset Retirement Obligation [Member]  
Total Realized Loss
Available For Sale Securities [Member]  
Total Realized Loss
Fair Value, Inputs, Level 1 [Member]  
Totals 13,002
Fair Value, Inputs, Level 1 [Member] | Asset Retirement Obligation [Member]  
Liabilities ,fair value
Fair Value, Inputs, Level 1 [Member] | Available For Sale Securities [Member]  
Assets , fair value 13,002
Fair Value, Inputs, Level 2 [Member]  
Totals
Fair Value, Inputs, Level 2 [Member] | Asset Retirement Obligation [Member]  
Liabilities ,fair value
Fair Value, Inputs, Level 2 [Member] | Available For Sale Securities [Member]  
Assets , fair value
Fair Value, Inputs, Level 3 [Member]  
Totals 21,116
Fair Value, Inputs, Level 3 [Member] | Asset Retirement Obligation [Member]  
Assets , fair value
Fair Value, Inputs, Level 3 [Member] | Available For Sale Securities [Member]  
Liabilities ,fair value $ 21,116
XML 33 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies (Details Narrative)
2 Months Ended
Jun. 30, 2016
USD ($)
shares
Depletion expense $ 386
Unevaluated properties $ 200,575
Potentially issuable shares | shares 32,762,153
Sales [Member] | Operator One [Member]  
Concentration risk percentage 54.00%
Sales [Member] | Operator Two [Member]  
Concentration risk percentage 46.00%
Accounts Receivable [Member] | Operator One [Member]  
Concentration risk percentage 35.00%
Accounts Receivable [Member] | Operator Two [Member]  
Concentration risk percentage 65.00%
XML 34 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
Acquisition (Details Narrative) - USD ($)
2 Months Ended
Jun. 03, 2016
Jun. 30, 2016
Business Acquisition [Line Items]    
Number of common shares issued for aquisition   $ (381,444)
First Titan Corp [Member]    
Business Acquisition [Line Items]    
Percentage of common stock owned 34.00%  
AngioSoma Research Nevada [Member]    
Business Acquisition [Line Items]    
Number of common shares issued for aquisition $ 20,000,000  
Percentage of common stock owned 66.00%  
XML 35 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
Intellectual Property (Details Narrative) - USD ($)
2 Months Ended
Apr. 29, 2016
Jun. 30, 2016
Value of shares issued for intangible assets   $ 2,990,535
Series A Preferred Stock [Member]    
Number of shares issued for intangible assets   5,000,000
Value of shares issued for intangible assets   $ 2,990,535
Medical Intellectual Property [Member] | Series A Preferred Stock [Member]    
Number of shares issued for intangible assets 5,000,000  
Value of shares issued for intangible assets $ 2,990,535  
XML 36 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
Advances Payable to Related Party (Details Narrative)
Jun. 30, 2016
USD ($)
Debt Disclosure [Abstract]  
Advances payable to related party $ 11,000
XML 37 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Advances (Details Narrative)
Jun. 30, 2016
USD ($)
Debt Disclosure [Abstract]  
Advances payable to third party $ 21,650
XML 38 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Convertible Notes Payable (Details)
2 Months Ended
Jun. 30, 2016
USD ($)
$ / shares
Total convertible notes payable $ 909,707
Less: current portion of convertible notes payable (512,493)
Less: discount on noncurrent convertible notes payable (376,773)
Long-term convertible notes payable, net of discount 20,441
Current portion of convertible notes payable 512,493
Discount on current convertible notes payable (143,438)
Long-term convertible notes payable, net of discount 369,055
10% Convertible Note Payable Due September 30, 2015 [Member]  
Total convertible notes payable $ 2,324
Issuance date Sep. 30, 2013
Debt instrument, face amount $ 528,434
Conversion price (in dollars per share) | $ / shares $ 0.04
10% Convertible Note Payable Due June 30, 2016 [Member]  
Total convertible notes payable $ 276,285
Issuance date Jun. 30, 2014
Debt instrument, face amount $ 276,825
Conversion price (in dollars per share) | $ / shares $ 0.03
10% Convertible Note Payable Due December 31, 2016 [Member] | Vista View Ventures, Inc. [Member]  
Total convertible notes payable $ 118,620
Issuance date Dec. 31, 2014
Debt instrument, face amount $ 118,620
Conversion price (in dollars per share) | $ / shares $ 0.01
10% Convertible Note Payable Due March 31, 2017 [Member] | Vista View Ventures, Inc. [Member]  
Total convertible notes payable $ 49,190
Issuance date Mar. 31, 2015
Debt instrument, face amount $ 49,190
Conversion price (in dollars per share) | $ / shares $ 0.005
10% Convertible Note Payable Due June 30, 2017 [Member] | Vista View Ventures, Inc. [Member]  
Total convertible notes payable $ 66,074
Issuance date Jun. 30, 2015
Debt instrument, face amount $ 66,074
Conversion price (in dollars per share) | $ / shares $ 0.53
10% Convertible Note Payable Due September 30, 2018 [Member] | Vista View Ventures, Inc. [Member]  
Total convertible notes payable $ 235,313
Issuance date Sep. 30, 2015
Debt instrument, face amount $ 235,313
Conversion price (in dollars per share) | $ / shares $ 0.75
10% Convertible Note Payable Due December 31, 2018 [Member] | Vista View Ventures, Inc. [Member]  
Total convertible notes payable $ 90,040
Issuance date Dec. 31, 2015
Debt instrument, face amount $ 90,040
Conversion price (in dollars per share) | $ / shares $ 0.08
10% Convertible Note Payable Due March 31, 2019 [Member] | Vista View Ventures, Inc. [Member]  
Total convertible notes payable $ 71,861
Issuance date Mar. 31, 2016
Debt instrument, face amount $ 71,861
Percentage of debt discount 60.00%
XML 39 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Convertible Notes Payable (Details Narrative)
2 Months Ended
Jun. 30, 2016
USD ($)
shares
Maximum percentage of the outstanding stock of the company upto which holder of the notes can convert the notes into shares of common stock 4.90%
10% Convertible Note Payable Due December 31, 2016 [Member]  
Accrued interest | $ $ 7,491
Number of shares issued | shares 1,498,124
XML 40 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stockholders' Equity (Details Narrative) - USD ($)
2 Months Ended
Jun. 28, 2016
Jun. 03, 2016
Apr. 29, 2016
Jun. 30, 2016
Number of common shares issued for aquisition       $ (381,444)
Value of shares issued for intangible assets       2,990,535
Series A Preferred Stock [Member]        
Number of common shares issued for aquisition      
Number of shares issued for intangible assets       5,000,000
Value of shares issued for intangible assets       $ 2,990,535
Medical Intellectual Property [Member] | Series A Preferred Stock [Member]        
Number of shares issued for intangible assets     5,000,000  
Value of shares issued for intangible assets     $ 2,990,535  
AngioSoma Research Nevada [Member]        
Number of common shares issued for aquisition   $ 20,000,000    
Convertible Notes Payable [Member]        
Accrued interest $ 7,491      
Number of shares issued 1,498,124      
EXCEL 41 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( $B2+TEFZG*XK@$ 'D5 3 6T-O;G1E;G1?5'EP97-= M+GAM;,V8RV[",!!%?P5E6Q%CIZ4/ 9O2;8O4_H";3(A%'%NV"?#WM0-4;916 MT!)I-GEPQW-O,LY9,'G;:;"#K2PK.XT*Y_0#(38M0'(;*PV55W)E)'?^UBR) MYNF*+X&PT6A,4E4YJ-S0A1[1;/)2@S$B@\'C7@B]IQ'7NA0I=T)5I*ZR5M>A MRG.10J;2M?1+8N>MXM2[% *P( L !?.0Q(OW[CMB PD.MQ-*O>X^NO ZIK XTHO8<4M?'5$Q^#*G* M_=ITJK$"2+8CCVG!D4*>-BP>-9?20D0[8$NP+,L5R*V.V:SGVL7.U49V[M,4 M1Y26M#;3"&>6X9MY6&3I//B)]!=C;IK>TI;MR5/0!_ZS#0//>997'L=V+YRO M+0O]C^AY%.!)T:'B1?4C9@,2[2F]@OIZ (4QOCLEFI2"(S>C@KN_V/P"4$L# M!!0 ( $B2+TDL!2\7>@$ %T4 : >&PO7W)E;',O=V]R:V)O;VLN M>&UL+G)E;'/%V$MJPS 0QO&K!!^@\HSR)LFJFVS;7D X$]LD?B"IM+E]72^* M^]#01>#;V-B"T7]A?@COVI!OG^3J8MVUH:K[,'MOKFW8#N_W615COS4F%)4T M+CQTO;3#ZKGSC8O#HR]-[XJ+*\5PGB^-G\[)#KN?LV?'TS[SQQ-ELQ?G2XG[ M[*WSEU")Q&#&&ST,&PS+MU[^LWUW/M>%/';%:R-M_*/"?&V0F700IX,8$F33 M0182-$\'S2%!BW30 A*T3 MC-&;%;T9=-;6#ML8O5G1FS%ZLZ(W8_1F16_&Z,V*WHS1FQ6]&:,W*WHS1F]6 M]&:,WE;1VV+TMHK>%J.W5?2VH'\E$[U#Y;R(MZO< M/V6&ULO5;?4^(P$/Y7,KR<]W 6BW=S MQV!G:NF),TH9B]YS3!?(&)*:I!WQKW?; A:M:'DX'NAFL]_^_)IT($VW/]$J M!6TY&/*T%-+T47G665B;]AW'L 4LJ3E&$XF[,Z67U.)2SQTUFW$&0\6R)4CK MN-WN+P>>+,@$DA_IUFG'&Q11_#05G%'+E?2N.=/*J)DEX1,#,7#>&I0(]!P# MRS2W*Z];V=15I4W,J( 8WDS*@Q45J_*TB90RY3*E5.MKKA\,+?I5 VIA3IJ M=Z/ROJ :$@RZXWVK+&U&*ZQ3%-A@0>4XB[]M"S;Z MRC?0A,OYA')MO$%N^SDPJ_1Z3+D]=$J)8L70S=T4\S,=:4VD[ MQ/!G7+J=*FRE+661&JN]?TH_F 6 -0-GJRS%NFU=YJ=>SRTM4-JU=+:5>>NV M[=1=:*;<"C#1;$*U_4^M*&O:-**W[D15Z,8%H3(AH;1(1W(IJU XO'I+ME(0 MC>/HZG+H3\,A.?>O_'$0DG@4AM.8'-V.#\#T/L?$4WQM,4$ MT?6D!::$C/SQ1>LX?CQJQ%R !$T%B?2<2OY<-KCL^WEFN(1FC$+VD$!)!KIY M&G&V7%*](FI&8CZ7'(F!5"0^8RK#>39B?/:8<<,_G/"EM" $TC+#=->'ZJK9 M4Y)3S,V0"5W1>P'$*G(# L^=!%5Z+Z:YL4KFQ6E;^!HK^^JYN7BKV,-"B03/ MFF\DQ*H^R#/.[@T\9@73PQS_FX/O[>7)[P,P?]H528ZF^&C/'O?D<_:0HR%8 MRH4A8ZHUXO/V];C-;^I^S.D!F)^?\?9]-?#]ZUQ^1;=GM=O,@RWFJXGM(4'A MH3VFUTR"IG>DEN2[6Z]^?;VYK)S=CRSO!5!+ P04 " !(DB])&H>D>C\! M !I P $0 &1O8U!R;W!S+V-O&ULS9--3\,P#(;_"NJ]2[N)":JN M!T".O"H M(%SM=6U"(=PLV2"Z@K$@-J!Y&,4*$Y,KZS7'&/HUBA[O=KXFF!0,:M!@,+!\E+.D>C5;8QM3LD%?E=%Q MS0/.K50K!?*N';?APF M._,W&-;=$/_6\621A'^_1S80RY8-[9)-NIL\ M!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&& M^+3&K!'@$WVWO@C(WXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\ MW*.76!4!EQC?-*HU+,76>)7 \:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX M?H;5,VPLCO='U!=*Y \FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z M> HWEL:\4*Z">P'_T=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY; MQ/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0C MI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[ MY\%1L*/O/)8=QXCRHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4 MX&1@+: '@Z]1 O)256 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM M(E(YPFF8$V>KRMYEL<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT, M"2Q;B%D2XDU=[=7GFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[ M2$R<><41 71% B.5' 86%S+D4.Z2D 83 >LX=S MFWJXPD6L_UC6'ODRWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F M6/,,H68XWX=%FAHSU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS< M_N\-L,+$CN'MB[\!4$L#!!0 ( $B2+TF+#@_53@( -H* - >&PO M]E89,,22 M/Y@Q&>FOGS\($*2T2==MX<77Q_>>>^QKN(25VE#\L,)8@8917D5PI53YV?.J M=(49JJ:BQ%ROY$(RI/14%EY52HRRR@0QZLU\?^XQ1#B,0UZS!5,52$7-500_ M=A!P\;9KLZHI\?2_\L^XC\ZDCRY[A'U->&VFO//PYSP?LRS* #XK!Z FM$M7]@ MW%-!A01*UUEKL A'##N/6T1)(HD!<\0(W3AX9@![-5H_1KB0-K?+,,XS]?M, MLD@BZ+?/X>F2GMT.9GN$TMWM:2 .2Z04EGRA)Z"UEYM2;XX+CIU(Z_>"=R'1 M)IA=#@+LH/,F0F98=ID#N(7BD.)XFQPX'U-C'P*C8FOJ@VC-_AK80_6&;(Y[2/LZ7M#D70(= MCXD^V$,?AVC+"E9"DB?M;RY"J@$L(5ACJ4@Z1'Y) M5"YQH]H;[#7Y/H6OW?+?U/3VI]:KT5?P7Q_/?TT^K(U]#>%(SP&EN*M9@N7" M?IN/%_;AZE25F;YYLM+FIROMA MZ_8?2O+8S#-K/3O/I4)#4A"K"MQJ0^5VX M,[KI3E_H&X_FS)J^Y]A5A1+]H[F319-E.$PH M(MC;WW%&:O;)*NC_9N/?4$L#!!0 ( $B2+TEE,M5U&PO=V]R:V)O;VLN>&ULE99;4^(P%(#_2J8OZ[XL-%Q6&7$&H2HS"HQEW>?0 M!LB8)IBD>/GU>U)$#Y)%?8$F;;XD)U]/SZGM/&IS/]/ZGCP54MF.Z49+YU:= M6LUF2UXP^TNON()[V,Q>2WW%C 4S8:C5B!>]&3S(BDEF7Y,+Q MO!LUH:D?^4Z'*5?GI9"^T:JWHIJ';;B$C.YZR4;@J+ MW<[;C6+:I+2]8?C'[@1_M!CH.PC+G%CS*9MUHWI$6.GTA9".FP%S_-+HJW6SU9""4*\>+7#2V[U(]7VH@7K1R3:6:TE-4H?Z,:!#/8MQY8 MHQ/9SH..S6[]272C=AV :V'%3$CAGKM1=2VYWTGMPU:J\+]?$54%9WO$A*F< M),H!A0S5YO @-'X-\/ PKR8V'0$79IC'FU!A4'\\2L?7PT%OF@S(>>^Z-^HG M)+U*DFE*COZ,$(@B$/TNJ(% #01J? )*I_!WDXP ,KX@XTERBT!-!&I^"]0? MWTP0J(5 K:^"*LY5;W2)0&T$:G]O1;WT"H%^(]#O?= E5]PP2<9FP91XJ-2\LR5$(:)@>QEW#,&8%WC@*^] M?,U@UY9,V#.#=X\X36Y]JN0Y=!F,PL+& 6.W*#P&NQF'Y-1J[5.$GWFDW?LZ M, 1[&0?$3)W.[I=:YI 0?Y $ KD; ZQC'/ Q+6>6/Y0^CR1K^-W9 58P#CAX MT('X&*.PA'' PL.H$XS"8L8!,_\;5W($^5GB?(;-I $S#[YD-,8H;"L-V+KS MFI&C 7=,2$M&S!C KC%J)\T&O#T8*XKS+,7>TH"WAU%-C,(ZTX#.AU$MC,)2 MTX#4*"'L1XK_Q"CL-PWX'4P2[U",PK;3@.T'TP7%ME-L.PW8_H;Z9'=8=?H] MU3T8?W&QZHV Z@=1#:QZ ZO>"*@>RDEHIQB%56_0U^+GO=Z!D@^^9;FO!FTU M#913F2\1X6^3XILMGP]\^P;*QF[D:SLHXTHI^] W5M>:5170AKPM"L_^ 5!+ M P04 " !(DB])WH/=AW@" F"0 & 'AL+W=OB(H\F#TG:J&MJ)BK>-OT?,>95IB%+\KVHN[>T\G?V#L M30]^GC9^J'.@-3U*'8*HRXWN:5WK2(K\UP;]8&KC_?T0_;LI5Z5_((+N6?VG M.LE291OZWHF>R;66KZS_06T-B0YX9+4PO][Q*B1K!HOO->0=KE5KKCW\$R-K M#1@--)0V0-T6A L:D4,C-U?2.2%#EGO2E9RKH.HR)XJ1JCG M9&)R\Z2*_%:$>7#381X4V"AVH$"C(E"QG0#LN^S8V/'7@#THHGE ] B R6UD M[/&\/7ZTQV"/C3UQY0>*'2C2>4#B!"3&GCT"6J-( 0 *E(08)7@>DSHQJ0FR MFJ@#%.MY0.8$9)"E.L)NBNW?J==N-8LHD9L"38S1%,5J M%G0(Q&PO=V]R M:W-H965T&ULC9A-VZ8;;]#". MQYLL&QX/IJV&:WLTG?MF;_NV&MUE_Y0-Q]Y4NSFH;3)@3&=M57?I=C/?N^^W M&_L\-G5G[OMD>&[;JO]S9QI[NDUYNMSX7C\=QNE&MMUDY[A=W9INJ&V7]&9_ MFW[@-W>BF"2SXD=M3L/J/)F*?[#VUW3Q=7>;LJD&TYC'<4I1N<.+^6B:9LKD MG'_[I/\\I\#U^9+]\SQ<5_Y#-9B/MOE9[\:#JY:ER<[LJ^=F_&Y/7XP?@YH2 M/MIFF#^3Q^=AM.T2DB9M]8K'NIN/)_RF8#Z,#@ ? .< P,+1:"[S4S56VTUO M3\EPK*8?C]\X>3\E<9D35]O@ACWG[.>!;SB$;F,*)1SV@AI7*U! MPLA#S9C*(R:> ^V$W$H>!4+&>8CPU7*D\9OYIECF2*D,P>PUP'=.9 M. TS1U1EB&:OX9RQ&*.2-D*@91$R\M!KUY\B* $:?$"H90A\KQ$J:DA @P\( MM0J!OVB BXC5 #3W@$RK$/=>PR-'1&,/PE<;,D*-UJ!9S)#HASL@]2KT=/<: M8%)&[%2 ;@Z X*M0<_ :$.4*N,M&=&\ Y%Z%>H/7:,YC?.C6 (B]"K4&K\FY M<-!&.-&] 9![]5]O6&ON%DU$3P7Z00\(O8K8]P@:>($PZQ"'7B.X(S'"B).E M"NY_OH@,-,D"*=4AP+PF>IOYZ#2A1 D1L MDP2-LT!4-?D$7M[:BL">+EN]S1ZK)_.MZI_J;D@>[.A>C.?WU[VUHW&)V+5* MDX.I=N>+QNS'Z31WYSV^D>/%:(_+'PSG?SFV?P%02P,$% @ 2)(O2;:= MZ0%5 @ E @ !@ !X;"]W;W)K,K42/>_,G9.0+=.F*\^1ZB5G1V=J MFRA&*(M:5G=A6;BQ5UD6XJ*;NN.O,E"7MF7R[XXW8MB&.)P&WNISI>U 5!;1 MS7>L6]ZI6G2!Y*=M^ 5O=CBS$J?X5?-!W;4#F_Q>B'?;^7'WABYM$%,Y,#DILRT74SI)EX6US);%]'5QGF0@&\'DAS= M))&)[D7$CP@"B!C\^+F?//H3\!/PQX\I=DZ20XH@P3C+$8S\(UCK%ZTX%>Z'-WN6VF),0FIM :)6&066."+=.PT_:-G/3EK!I0D>+?CH# MW XBY3]02P,$% @ 2)(O24^LXMED @ /@@ !@ !X;"]W;W)K)E5]V)[=Q FH M@)GMA.[;S_8E-*E<@B(%XYQS?\?"%Z<8N'B3%6/*>V^;3F[\2JE^'01R5[&6 MR@?>LT[_\'HWIK:)L!AF 8MK3N_+.SMDS3M/L,/&?T3K+4J-Q"I^UVR0 M5V//A'_E_,W<_-QO_-!D8 W;*5."ZLN9/;&F,94T^>]8](-IC-?C2_7O=KDZ M_BN5[(DW?^J]JG3:T/?V[$!/C7KAPP\VKB$Q!7>\D?;;VYVDXNW%XGLM?8=K MW=GK +_DX6AS&_!HP),ARFQP -F8WZBB92'XX,F>FH>'UEHN3!%=V=/9I%ZV MK2GLPLOB7.9I$9Q-G1L)^+8@09,BT,6=!.R[[-C:L_"^/[KU1Y P@H39?7]\ MZX_!'X,_OUUA9R491 0)2M/D/B1QADP 0N[[4V?(U/I)Z J90DB0H#"_S\B< MC P8:(8!DNAJ.WS)R)V,'!AXA@$2A!=L*.)D$&!$,PR0X 1?)?F2@D(GQDYK M3CS#&34X(>&"_8F0&P0-1I(Y$&A6.-:?!23LW*4(>I$L>+PH%;B397%;0 MK!*29DM([K9%T)1DKF]'S2J/"%K0%BAQDZ!Y"9DC@6;!2PRY&QQ=VG>NQ2^B M/,O#)/Z\HX*K]WO+Q-$>8]+;\5.GX/4^S4Y'Y2.VY\.'O"QZ>F2_J#C6G?1> MN=*GC#T,#IPKID.$#XGO5?HPGVX:=E!FF.FQ@.,-;A3O+Z?U])>A_ ]02P,$ M% @ 2)(O2303CI7/ 0 @P0 !@ !X;"]W;W)K9LX./!;5"[5-Z/S[\4)H M,D*3"U[XM@?/+B:IWG4'8- G9T+O<6?,L"-$5QUPJN_E ,*^::3BU-BE:HD> M%-#:DS@C213EA-->X++P>Z^J+.1H6"_@52$]UQC,\;;WW;&;=! MRH(LO+KG('0O!5+0[/%3O#OD#N$!OWJ8],4Q'*=_=XD>]QY&+ PJXQ2H M'4[P#(PY(6O\,6M^63KBY?RL_LU7:],?J89GR7[WM>ELV BC&AHZ,O,FI^\P ME[!Q@I5DVC]1-6HC^9F"$:>?8>R%'Z?P)H]FVCHAF0G)0DA"\&#D8[Y00\M" MR0GI@;I_%^\L7#D1JXQL-FW+]IK*%UX6IS*.XH*\],0,9TC)K<%LFN!+ AD7N!Q>UVB\)"'D#% [K;I8[R];;-9 MM=G,.=,UGSSX!,Q=EN79;9M\U2:?;;+_E)//Y6S3[;]?C5QT"0?5^L.@425' M84*3++O+>7M*?)=]PR,L"P:- M<=,'.U?AD(2%D&PO=V]R:W-H965T&ULC9=-*IX=>5.0.0^)7Q:STYM[K!OPCQVEU\/RQMU(V!YWS?="'2]O#. M(Y[G7:0V\Q\(^IFS$T[/A^AQ/]UV^"]IS2.1_\X.S;D=+;*M S^F;WGS4UP3 M#G-@7<"]R.O^U]J_U8TH!HEM%>F'/&9E?[S*?P($,K6 @(", D*T A<$[BAP MJ59 04#O%3 0L$^!IQ5X(/!& 0VT A\$_N>D0ZT@ $$P"G#ODB/+T1=SDS;I M:E&)JU5?TFZ)XZ<6K[H@;62KK6#=+HX^9M4OC]7B?8416SCO7: ;AO3,>F"\ M>28:&'^>V0Q,,,]L!R:<9V)@,)IG=@.#YYED8,C(.*UO2O/(K7E4FD<@@'N; MI.P97YH'#$+$50U%1HHDQ8+Y0)LQD'+:,LY6'6>*Q&9D9QY-,DQ].JU9]URE M>RZ$H*HTGG3/'=TCC"IMEN!F!-'4H-D1T=L1N7)$%$;$S &8 >Y[9/3.R,2-; M-3*=>;W9/C4QGM 4D##4O MO=B<:F=.E4C$IR$V>Q$ MH5_XOPF:YHH 8G<73=U78.@%B+*Q@,<,(!5W)'* MBT9DT;0^3JCYL MSS1Q$E3 &3A)]^]G[(\T[3X1[R6 <[YSC@W'E^*L^M=A+Z4.WMJF&Y;A7NO# M?10-Z[ULJ^%.'61G_MFJOJVT>>QWT7#H9;6Q16T3,4*2J*WJ+BP+V_;4EX4Z MZJ;NY%,?#,>VK?H_*]FH\S*DX=3P7._V>FR(RB*ZU&WJ5G9#K;J@E]ME^$#O M5YR,$(OX6"1:"B P[*L%"K)R!1'J; M@'\DX,XC!X+L-H'X2" <@7 $]%,G.XM)G4N'660\IQXZ,6HT!J/Y;8($-9HX M DXPHXDSZC Q\1C.%!5)083.B#A,S @7MV4R=# RD&&W"7+49PX$?,:GPRP$ M\;!)"2ICFT^E$#,R@*&,.S0@ZTH&:N M]D@VQ9-)(9H\]J# LTDAG!P-Y^36@>(D)QY",2X$Z>3IG%#\/T()/BA3BGT^ M%3RB=,IH/N<50#$E/F8S7 EB*N:FG GDJ83'F4*>Q=R\ Z LS3SF4(8'FD%8 MKR+T#V@%H-CC'3$\S@R613$W/P'(LS\,_9X8Y%EXS'&,XUXAIR*>&Q+N/R1X MEAED6:"[B4E&^,O@RRR#) N/)9#A"RV#C(IL[N4Y4.HQN3$\QPPB*M (S9E-"Y& .(Y3F)?69LA@>9Y=-L,-90Y1)FC& M0 I "R&2SPF)KK;$K>QW=N<_!&MU[+3;$5]:+Z>+!V:WU._PLCA4._FCZG=U M-P0O2IN-N=T_;Y72TC@@=W$8[,WYY_+0R*T>;U-SW[L3@7O0ZC =<"ZGK/(O M4$L#!!0 ( $B2+TE06B>.H $ +$# 8 >&PO=V]R:W-H965T&ULA5/+;MLP$/P5@A\0RK+<%H8L($X1M(<"00[MF996$A&2JY"4 ME?Y]^9 4.S":B[B[FIF=Y:.N6'/F*U[4-S>X0#:_VG1 M*.Y\:CIF!P.\B20E69YE7YCB0M.JC+4G4Y4X.BDT/!EB1Z6X^7L$B=.!;NA2 M>!9=[T*!525;>8U0H*U 30RT!WJ_V1^+@(B WP(F>Q&3X/V$^!*2G\V!9L$" M2*A=4.!^.<,#2!F$?./76?.]92!>QHOZ8YS6NS]Q"P\H_XC&]=YL1DD#+1^E M>\;I!\PC[()@C=+&+ZE'ZU M%$H4?TNKT'&=TI]OV4R[3&7BO5D_=M0T;75ZRCOO\W@F[_"J''@'O[CIA+;DA,Z?;#R %M&!;Y_=[2CI_?M9 M$PFM"^%7'YMTI5+B<%@>R/I*JW]02P,$% @ 2)(O24\:&PBC 0 L0, M !@ !X;"]W;W)KP)$W M);4]T-ZY8<^8K7M0W-[A -K_:=$H[GQJ.F8' [R))"59D67W3'&A:57&VK.I M2AR=%!J>#;&C4MS\/8+$Z4!SNA1>1->[4&!5R59>(Q1H*U 3 ^V!/N;[XS8@ M(N"7@,E>Q"1X/R&^AN1'D[S"/L@F"-TL8OJ4?K4"T42A1_2ZO0 M<9W2GTT^TVX3BIE0K(0O632>&D6;7[GC56EP(G;@X>SRO8>;(.*5B?=F_=A1 MT\3!J_)?RZP MO1;8)H'M_T9,F..">?C0A%WLJ0+3Q:MC28VC=FE+U^IZ.Q^+>";O\*H<> <_ MN>F$MN2$SI]L/( 6T8%OG]WM*.G]^UD3":T+X8./3;I2*7$X+ ]D?:75/U!+ M P04 " !(DB])IJKV&J0! "Q P &0 'AL+W=OP)$W);4]T-ZY8<^8K7M0W-[A -K_:=$H M[GQJ.F8' [R))"59GF7W3'&A:57&VK.I2AR=%!J>#;&C4MS\.8+$Z4 W="F\ MB*YWH<"JDJV\1BC05J F!MH#?=SLCT5 1,!/ 9.]B$GP?D)\#]9\[UE(%[&B_K7.*UW?^(6GE#^$HWKO=F,D@9:/DKW M@M,WF$?8!<$:I8U?4H_6H5HHE"C^EE:AXSJE/\5VIMTFY#,A7PD/632>&D6; M7[CC56EP(G;@X>PV>P\W0<0K$^_-^K&CIHF#5^6YVNP>2G8.0E>81#S.F!7! MO/K-%CF]1<\C/?^8OKVF;Y/#[>SP_F.!XEJ@2 +%_T9,F.."^?Q/$W:QIPI, M%Z^.)36.VJ4M7:OK[7S,XYF\PZMRX!W\X*83VI(3.G^R\0!:1 >^?7:WHZ3W M[V=-)+0NA)]\;-*52HG#87D@ZRNM_@)02P,$% @ 2)(O23L)N!NB 0 ML0, !D !X;"]W;W)K&ULC5/+;MLP$/P5@A\0 MRI*3%H8L($X1)(< 00[MF996$A&2JY*4E?Y]^9 4NS#:7L3=U357BZ*30\&J('97BYM0/#=[F@4+(*%V08'[Y00/(&40\HU_SIJ?+0/Q M/%[4'^.TWOV16WA ^4,TKO=F,TH::/DHW1M.3S"/&H4;7[CCE>EP8G8@8>SV^P\W 01KTR\ M-^O'CIHF#EZ5IVISEY7L%(0N,(EXF#$K@GGUJRUR>HV>1WK^;WIQ22^2PV)V M^!_]MY<"VR2P_=N("7-8,'^Z9&=[JL!T\>I84N.H7=K2M;K>SOL\GLDGO"H' MWL$+-YW0EAS1^9.-!] B.O#MLYM;2GK_?M9$0NM"^,7')EVIE#@ROM+J M-U!+ P04 " !(DB])P_&KJJ,! "Q P &0 'AL+W=O*FQL-3&C4ES_.8#$:4\W M="F\B;:SOL#*@JV\6BCHC<">:&CV]&ZS.^0>$0"_!$SF+";>^Q'QW2?/]9XF MW@)(J*Q7X&XYP3U(Z85 M&P6;#]SRLM X$3-P?W:;G8-K+^*4B?-FW-A!4X?!R^)4;FZS@IV\T 4F$@\S M9D4PIWZU14JOT=- 3[^G9Y?T+#K,9H?Y]P+YI4 >!?+_C1@QAP6S_:<).]M3 M!;H-5\>0"L?>QBU=J^OMO$O#F7S!RV+@+;QPW8K>D"-:=[+A !I$"ZY]2#K*RW_ E!+ P04 " !(DB]);_J2J*,! M "Q P &0 'AL+W=OP)%W);4]T-ZY8<^8K7M0W-[A -K_:=$H[GQJ.F8' [R))"59GF4[IKC0 MM"IC[<54)8Y."@TOAMA1*6[^'$'B=* ;NA1>1=>[4&!5R59>(Q1H*U 3 ^V! M/FWVQR(@(N"G@,E>Q"1X/R&^A>1[L^=$R M$"_C1?UKG-:[/W$+SRA_B<;UWFQ&20,M'Z5[Q>D;S"/&D6;7[CC56EP(G;@X>PV>P\W0<0K M$^_-^K&CIHF#5^6YVNQV)3L'H2M,(AYGS(I@7OUFBYS>HN>1GG].WU[3M\GA M=G;X\+E <2U0)('B?R,FS''!//[3A%WLJ0+3Q:MC28VC=FE+U^IZ.Y_R>"8? M\*H<> <_N.F$MN2$SI]L/( 6T8%OG]W=4]+[][,F$EH7P@F9QSYHPOQ8CFPW8 CGPIJ>V6=L[U&\9LU8'B]@I[ MT/Y/@T9QYU/3,ML;X'4D*\2/D#S7 M6YH%"R"A!H?U1_CM-[]GENX1_E;U*[S9C-* M:FCX(-T;CD\PC7 =!"N4-GY)-5B'ZDBA1/&OM H=US']R=<3[3(AGPCY3+C- MHO'4*-I\X(Z7A<&1V)Z'LUML/-P$$:],O#?KQXZ:)@Y>%H=RV=*[.M_,NCV?R#2^+GK?PPDTKM"5[=/YDXP$TB Y\ M^^SJFI+.OY\YD="X$*Y];-*52HG#_OA YE=:_@502P,$% @ 2)(O2216 MN 6C 0 L0, !D !X;"]W;W)K&ULA5/+;MLP M$/P5@A\02K(3%X8L($Y1M(<"00[MF996$A&2JY*4E?Y]^9 4.S":B[B[FIF= MY:.N6'/F*U[4-S>X0#:_VG1*.Y\:CIF!P.\B20E69%E M#TQQH6E5QMJSJ4H#\AOH;D1W.@6; $FH7%+A?SO $4@8AW_C/ MK/G>,A OXT7]6YS6NS]Q"T\H?XO&]=YL1DD#+1^E>\'I.\PCW ?!&J6-7U*/ MUJ%:*)0H_I96H>,ZI3_%;J;=)A0SH5@)7[)H/#6*-K]RQZO2X$3LP,/9Y7L/ M-T'$*Q/OS?JQHZ:)@U?EN@*DXC'&;,BF%>_V:*@M^A%I!>?TS?7 M]$URN$G='W:?"VRO!;9)8/N_$1/FN& ^NF07>ZK =/'J6%+CJ%W:TK6ZWL[' M(I[).[PJ!][!3VXZH2TYH?,G&P^@173@VV=W]Y3T_OVLB836A7#G8Y.N5$H< M#LL#65]I]0]02P,$% @ 2)(O29G9(2>C 0 L0, !D !X;"]W;W)K M&ULA5/;;J,P$/T5RQ]0$R!-%1&DIJO5]F&EJ@^[ MSPX,8-5F6-N$[M_7%Z#)*MJ^X)GAG#-G?"DFU&^F [#D7'&AG[;!GS%0= M*&[N<(#>_6E0*VY=JEMF!@V\#B0E69HD]TQQT=.R"+47718X6BEZ>-'$C$IQ M_?<($J<#W="E\"K:SOH"*PNV\FJAH#<">Z*A.=#'S?Z8>T0 _!(PF8N8>.\G MQ#>?/-<'FG@+(*&R7H&[Y0Q/(*47H M;>?,)I34T/!1VE>XBCZL4_R3[6;:;4(Z M$]*5\) $X[%1L/F-6UX6&B=B!N[/;K-W<.U%G#)QWHP;.VCJ,'A9G,O-+BO8 MV0M=82+Q.&-6!'/J-UND]!8]#?3T:WIV3<^BPVQVF'\MD%\+Y%$@_]^($7-< M,-M_FK"+/56@VW!U#*EP[&W&ULA5/+ M;MLP$/P5@A\0RK(3IX8L($X1M(<"00[MF996$A&2JY"4E?Y]^9 4.S":B[B[ MFIF=Y:,8T;S:#L"1=R6UW=/.N7['F*TZ4-S>8 _:_VG0*.Y\:EIF>P.\CB0E M69YE=TQQH6E9Q-JS*0LQ:3X/V(^!J2G_6>9L$"2*A<4.!^.<$C2!F$ M?..W2?.C92">Q[/Z4YS6NS]R"X\H_XC:==YL1DD-#1^D>\'Q!TPCW ;!"J6- M7U(-UJ&:*90H_IY6H>,ZIC_YMXEVG9!/A'PAW&?1>&H4;7[GCI>%P9'8GH>S M6^T\W 01KTR\-^O'CIHF#EX6IW*UO2O8*0A=8!+Q,&$6!//J5UOD]!H]C_3\ M:_KZDKY.#M>3P^W7 IM+@4T2V/QOQ(0YS)C[3TW8V9XJ,&V\.I94.&B7MG2I M+K?S(8]G\@$OBYZW\(N;5FA+CNC\R<8#:! =^/;9S2TEG7\_2R*A<2'<^MBD M*Y42A_W\0)976OX#4$L#!!0 ( $B2+TEQKX<]5 ( .L( 9 >&PO M=V]R:W-H965T_OYER:59;@!VWP_QSK'/E0C9>^\P5B CX[T?!(/]$!]_++F;(."3EEEY@/#*.3)G4D3I,DCSO4]E%=Z;575E?T*DC; MXU<&^+7K$/NWQX2.NPA&;N&MO31"+<1U%4^\4]OAGK>T!PR?=]$SW.YAH2 : M\;O%([\; Q7\@=)W-?EYVD6)B@$3?!1* LG7#;]@0I22=/YK13\]%?%^[-2_ MZ^W*\ ^(XQ=*_K0GTO'NDK$^'*N&?Y MO,#Z46!M!-9&8)/XMF@P>X=9L,G,:Y)9@31@XC"K>9/<:Y);@77 Q&&R>9/" M:U)8@3Q@XC#%O,G&:[*Q IN B<.4\R:EUZ0T F4H\0ZS(/$P\;KH92412OT$ M6I!["/T^]AB6H>Q/H 7IAZG?)[42H0*80 LJ *[\/O9@EZ$:F$ +B@#ZCS\T M9UOVI)"/ RVI _\- #,K$:P#!UI2!_Y+ .96(E@'#K2D#OSW "RL1+ .'.AK M'<1WS:C#[*)[+@='>NV%Z473ZM37GU/=S#[A=36@"_Z%V*7M.3A0(5NB[EQG M2@66_LE3%H%&_GE,$X+/0@T+.6:F%YN)H(/[M9C^;^K_4$L#!!0 ( $B2 M+TF]>O5(L $ !8$ 9 >&PO=V]R:W-H965T]Q9V^\(,54'@IH;U8-T;QJE!;5NJUMB>@VT#B3! M298DMT10)G%9A-R3+@LU6,XD/&ED!B&H?C\ 5^,>IWA./+.VLSY!RH(LO)H) MD(8IB30T>WR?[@ZY1P3 "X/1G,7(UWY4ZM5O_M9[G/@2@$-EO0)URPD>@',O MY(S_3YJ?EIYX'L_JOT.WKOHC-?"@^#]6V\X5FV!40T,';I_5^ >F%D*%E>(F M/%$U&*O$3,%(T+>X,AG6,;ZY2R;:.B&;"-D7 HE&HW4XL^U%B/F,&'2Y+I)OFJ23P+I-R8SYNNG(&># M$Z#;<#X-JM0@;9S;DEVNP'T6!O\)+XN>MO!(="@0YM&=:&DE$2(U*4E;Z]^4B*79@(!=Q9O26&2[EC/K- M] "6O"LYF /MK1WWC)FZ!\7-'8XPN#\M:L6M2W7'S*B!-X&D),N2Y)XI+@9: ME:'VHJL2)RO% "^:F$DIKO\=0>)\H"E="Z^BZZTOL*ID&Z\1"@8C<" :V@-] M2O?'PB,"X+> V5S$Q/=^0GSSR<_F0!/? DBHK5?@;CG#,TCIA9SQWT7SP](3 M+^-5_7N8UG5_X@:>4?X1C>U=LPDE#;1\DO85YQ^PC+#S@C5*$[ZDGHQ%M5(H M4?P]KF((ZQS_Y(\+[38A6PC91GA,0N/1*+3YC5M>E1IG8D;NSR[=.[CV(DZ9 MN-Z,&SMHZC!X59ZK+,U+=O9"5YA(/$9,NB&84[]ID=%;]"Q:?$W/K^EY[#"/ M[O\*D?>P2^N.S$8O=^MD1":WWXX&(=KU1,+([K M ]E>:?4?4$L#!!0 ( $B2+TG@;!EXG ( ($* 9 >&PO=V]R:W-H M965T!-#Z>!=%:G/@ M#5,WXLA;U53+.?T#TP],2+]N]^D.W M7#/]%Z;X2M3/U58?S&SC,-CR'3O5^DFJ[:YG=R?#0/,3,!#P0,!HE$" 0.82*!#H!R$>)21 2 8"&2>D0$B_3"ER MQ>I*?<\T*PLISH$Z,OL"HCL#EU;$* >FOLH\NDY3=@^O+-Y*C-(B>K-"GS"X MPRQ[3'8=L^HQ^77,?8^YO8Y9 P;'US$/#D,^()%9KG?-^/.:J5LS!@_TV:/M M,)GS<)AO)$>4TFDCXC4B8(2G!:A7@(( \57#898]9L8L$Z]) @+)M$#J%4BG MZ[D$3.Q^TTZ9URF;48\>DTZ;Y%Z3' 2R:8%;K\ M".2^>CCBO<.0:0L4>SVZ M86OB#1.%P %H3E00\OM ( F:(>&/&\+3]5@#:(Z+/VL(PD;P]8*L!]" (G;D9(/]N@"#J9"0#JQY$Y_CX-P0$.P(=V>!6 $*4X/3K5AQ= M?)F/;,]_,;FO6A6\"&T^\MVW>">$YD8GOC&G@8,Y#PZ=FN^T;6:F+=T)R76T M./8'ON'46?X#4$L#!!0 ( $B2+TE#JRU&TP$ (8$ 9 >&PO=V]R M:W-H965THYBD>M,M@$'O@O=ZCUMCAATANFI! M,/T@!^CMDUHJP8P]JH;H00$[>9+@A$913@3K>EP6_NY%E84<#>]Z>%%(CT(P M]?L 7$Y['./+Q6O7M,9=D+(@"^_4">AU)WNDH-[CIWAWR!W" WYT,.FK/7+9 MCU*^N<.WTQY'+@)PJ(Q38'8YPS-P[H2L\:]9\\/2$:_W%_4OOEJ;_L@T/$O^ MLSN9UH:-,#I!S49N7N7T%>82,B=82:[]+ZI&;:2X4# 2[#VL7>_7*3Q)\IFV M3J S@2X$&H('(Q_S,S.L+)24_G"R^) B8>$$0J[YJ0?$:G7IZ$MWG)[?\)$1,@GV6WQ=(;P72() &@3B_ MK;'WF,<0,F VV^13O+WODZWZ9/.[3-9\\N 3,)O83LA_O-!\U2>??=)_U!,P MFSS=QO3O@LA5HPA0C9\'C2HY]B;TR7*[C-P3]8WV 2^+@37PG:FFZS4Z2F/; MU7=5+:4!&R%ZR#!J[4=A.7"HC=L^VKT*4?4$L#!!0 ( M $B2+TF>>O2+@@( -\) 9 >&PO=V]R:W-H965T1W89/K*Y:]$H<>FH:2/XM48TO"Q>X_<1; M=2R9F/#RS!OB]E6#6EKAUB'HL'!?P+P @4 D\;M"%WKS[HC%;S%^%X.?^X7K MBS6@&NV8D(#\<48K5-="B6?^JT6O.47@[7NO7DB[?/E;2-$*UW^J/2OY:GW7 MV:,#/-7L#5]^(.TA%H([7%/YZ^Q.E.&F#W&=!GZH9]7*YT7]DT8ZS!P0Z(!@ M" #)PX!0!X37@,<9(AT030V(=4 \-2#1 1#%F7<60G=,()EESR0#XW%]8Y+ -0D$6B = M3[+JF=DXL^Z9YW%FHYG8'V<*S=CMA/=V0E6S4*< =H'H7B!2 I$6"$QK5,Q2 M,;&Q' I9F9%6(JFJF$*B- 1@G-HH"L1AD$1V3['14ZP]A0\\Q79/=F1M1S9? MD%$SB=%,HLU$#\PD=C-V9&U'-E^043.IT4RJ=A<\.FVIW8P9N3MMZ:33EG[K MM,V,G^!,;U!L%W@V%N79_ G>+K30C._'Z80\P#0H^PGJ[/"I9>KZ&&:'GN5%MBR?YI=@ MOE&=QU4FSSIX1+\@.58M=;:8\2M4WG0'C!GB2_.?^%U;\FYK&-3HP,1KRM^) MZC_4@.&N;Z>&GB[_#U!+ P04 " !(DB])!+/_:(H" "\"@ &0 'AL M+W=ODT3N:]91^< 'UNLG1RXZJO14G!(Y"$8/-JEK$TC3/.EHT\=5:==>1%7R MLVJ;GKV(2)Z[CHI_6];R<1.3>%IX;4ZU,@M)529SWJ'I6"\;WD>"'3?Q$WG< M0F9";,3OAHWR:AP9\3O.W\SDYV$3IT8#:]E>&0BJ;Q?VS-K6(&GFOQ[T@],D M7H\G].]VNUK^CDKVS-L_S4'56FT:1P=VI.=6O?+Q!_-[L KWO)7V&NW/4O%N M2HFCCKZ[>]/;^^B>%"N?AB> 3X Y 9QP1V1E?J.*5J7@8R0':EX>>=3APH!H MY$AKDWK;%E/8C5?EI8(L+Y.+ ;J)<8E;%T/FB$2CHQ008^E@TQ?I_?S%;?[2 M25QXB04FT<5L74RVNL^Q1#F6GB, ($,!L@"16;#('.7(/2GD> (%[B63X$;@M:[B; M"&XGXOV4%P$0N*%($7( PBU%<$^1R50A$+BKR!H_ +=*U\%* 3<53*8*^$8! M;BH@ 1^ *8@0$G#. /<5>%\5 =\JP'T%G_CJIJP0_G<"W%3@356$_(1Q4T&& M'U57UL(KS3XM:W+5771,G&P3):,]/_?*-1?SZMRH/8'M3C["JW*@)_:+BE/3 MRVC'E>YQ;"MRY%PQK2!]R.*HUJWD/&G949EAHBHNL1P$P2=;Q&B,DB2/&>[ZJ*[LVJNH*WY5M.O)JP#RRA@6?PZ$\G$? MP6A:>.LNK3(+<5W%<]VI8Z27'>^!(.=]] QW!Y@:B57\[,@H[\; A#]R_FXF MWT_[*#$9""6-,A987V[DA5!JG#3YMS?]9)K"^_'D_M5N5\<_8DE>./W5G52K MTR81.)$SOE+UQL=OQ.\A,X8-I]+^@N8J%6=32008_G#7KK?7T=W)4U\6+D"^ M ,T%J+#!',O=44#N(T:9DO0S9! MR,9#-O^!>$V29$6VS,F"G,QSLA G=QRG25&1(YBERZ0\2,H]:<4C*8(&A34R;+$)@$*7;96*SX#" ,6\ 522=1 MB59P4)B#O,6*-P>&OSB8KHGJ1>7F'TY\UX@8$1?;;R5H^+57K@_-JW-/?T:V MD7W*ZVK %_(#BTO72W#D2K=#V[7.G"NB^&PO=V]R M:W-H965TBE.6/8"2&5)C.(X#'/,2-L%96%KKZ(L^%G1MH-7@>29 M,2)^[X#R81M$P5AX:T^-,@5<%GCB52V#3K:\0P+J;? 4;?91:" 6\:.%05[- MD3%_X/S=++Y5VR T'H#"41D)HH<+[(%2HZ0[__*B?WL:XO5\5'^Q<;7] Y&P MY_1G6ZE&NPT#5$%-SE2]\>$K^ R9$3QR*NT_.IZEXFRD!(B1#S>VG1T']R7- M/6V>$'M"/!&B]+^$Q!.23P3LG-E8V&)V(R;_-V;O,1,":P>S-N);&Z[X%/L6JV6!Y%8@ M=0*)$XBC6X^=Q:R<1X?YDJRC-$V7&Z6SC5+?Z(ZHV6S4[/ZH^:R#W#M(YH[# M878CYHZ8J]DF*R^0+0NL9V.N[X_Y..O@O)";X3<6H[B0Y&ULE53;;ILP&'X5BP>H.81 (H*T9*JVBTE5+[9K M)_P$5!M3VPG=V\\'8,GDE98+?/I._BV[&+AXD0V 0F^,=G(7-$KU6XSEJ0%& MY /OH=,K-1>,*#T49RQ[ :2R)$9Q'(9KS$C;!65AYYY$6?"+HFT'3P+)"V-$ M_-X#Y<,NB()IXKD]-\I,X++ ,Z]J&72RY1T24.^"+]'VD!N$!?QL89 W?62R M'SE_,8/OU2X(302@<%)&@>CF"@>@U AIX]=1\Z^E(=[V)_5'NUN=_D@D'#C] MU5:JT6'# %50DPM5SWSX!N,64B-XXE3:/SI=I.)LH@2(D3?7MIUM![>2330_ M(1X)\4R(5N\2DI&0_$/ +IG=UU>B2%D(/B#9$W/8T5;#A1'1RDAO1NHZ64UA M*U46US+.\P)?C= =)K:8_839_!]S&#$S NL$WACQ?8R5BQ$[^B:\M^@L)G,6 M$V83IDFZ;)1XC1(K$H79LL#**[ :4T2^I&N7U&'2T'[+1JG7*/U 2=+/E63M M-5J/(A\XO,PKD"V79)]]KB2YURA?+LD^?Z* 0 .0, !D !X;"]W;W)K&UL MA5/+3L,P$/P5RQ^ \^A#5&DD"D)P0$(!K!\[:IHX>%WMZ^*VK-@^"%U@$G&5,&4V0IB7O]JCN.Q1IAY% MY.>S^?\"Y:7 ) F446 RO_2H(V2>/"9(GF?97YOL[%AZOH47;K9"6[)&YT\X M'D2+Z,"K9#=32CK_CL="0NM".O>Y25>;"H?]Z:&.?TO] U!+ P04 " !( MDB])ZG>#^XD! Z P &0 'AL+W=O> MF9VUG6I \V$[ $>^E-1V13OG^B5C=MN!XO8*>]!^IT6CN/.EV3';&^!-)"G) MBBR;,\6%IG45UUY,7>'>2:'AQ1"[5XJ;[S5('%8TI\>%5['K7%A@=<4F7B,4 M:"M0$P/MBM[FRW49$!'P)F"P)SD)WC>('Z%X:E8T"Q9 PM8%!>[# >Y RB#D M&W^.FK\M _$T/ZH_Q&F]^PVW<(?R732N\V8S2AIH^5ZZ5QP>81QA%@2W*&W\ MDNW>.E1'"B6*?Z4H=(Q#VBF+D7:94(R$8B(4R7AJ%&W><\?KRN! ;,_#W>5+ M#S=!Q"L3[\WZL:.FB8/7U:$N;JXK=@A"9YA$7"=,F4T0YN4O]BC.>Y2I1Q'Y M^7SQOT!Y+G"=!,K1Y.S&ULE9A= MCYLX%(;_"N)^BGULOD:92)U65?>B4M6+W6LF<1)4P"F02???%[!-9U:GF7=O MPD=>G]>'PV,;;ZZV_SZU/MET9MDY 06=)6=1=O-\N]K_UV8R]C4W?F:Q\-E[:M^G\?36.O M#[&,PXUO]?$TSC>2[299V^WKUG1#;;NH-X>'^+V\?]3E+%D4?]?F.KPXC^;. M/UG[?;[X:_\0B[D/IC&[<0Y138=G\\$TS1QI'*I+,WZSU\_&YY#. 7>V&9;?:'<91MN&)G'45C_= ML>Z6X]7]4PC?C&] O@&M#93KN#-:NOFQ&JOMIK?7:#A7<_'D_23OYR!3Y&CJ MVS"EO<3LE\2WF^9X#O=*XAH].(U=%,D5G+2CFFI.WR-\.H%X'T*Z/ MR@Q6S2Y,W&:4I2Y 'PTZZ.]3\GY9,[':>Y22;I4;QNEK%&Z!%%"W#!R MFCN59WD.&&6L4>:-Y TCIR&A-5#AG+7)O0W=L'$:]+D5K$_A?=0-'Z>YDUII M5;QM5+)&)?#>*F]%?OLYJ%]\7(J\0ZJ$H^\#,R70 @> M9IDAA?:B/*,">2UYH&6.E-J+I !\>*!E@92Z""D5A*3$(RU+J-1E*#4P2!'/ M-'FF)3)C\DP3PK0725ED!)2 >*H)H3J() $^/-6$4.U%<$H\U01132O52)UX MJLE3+9&WA:>:$*J]2)>R1!X+#S4A4 >1!(8ZXJ$F!&HO0C/BF::;3)?>:45: M *.'XIE6@6DD!,^T0ICVHBP3.5 Q2.M$*2#2 (3M?K#NAQ!VHO0C'BB%42T M"D2G (Z*)UH%HI&O%9YHA1 =1"J%!@_%(ZT0I(-( LMAQ2.M$*2]"$Z)9UI! M\[0*4.< D)IG6@>F@269YIG6"-->5 JA@:%.\TQKA.D@0N9.S3.M$::U^E\9 M_>%K&V):K[,T\/9JGFGMF29@HM<\TQIAVHOR:?6"./%(:P3I(")@/:9YI#6" MM!>A&?%$:T\TJ5L9!=%_)XGDQ:Y6:_KCLGDW1#M[Z4:WJ;7>73<(W].R*_9; MOMV-.8PSJ?Y=-Z[33UW M,=ISV*-<-TJWOP!02P,$% @ 2)(O20B^6ZS- 0 @@0 !D !X;"]W M;W)K&ULC53;;ILP&'X5BP>H@7!((H+4=)JVBTE5 M+[9K!WX.J@_,-J%[^_D -*F0VAOLWWPGPV\7DY"OJ@/0Z(U1KDY!I_5PQ%A5 M'3"B'L0 W+QIA&1$FU*V6 T22.U(C.(X##/,2,^#LG!KS[(LQ*AIS^%9(C4R M1N2_,U QG8(H6!9>^K;3=@&7!5YY=<^ JUYP)*$Y!8_1\9Q9A /\[F%2-W-D MLU^$>+7%S_H4A#8"4*BT52!FN,(34&J%C/'?6?/=TA)OYXOZ=[=;D_Y"%#P) M^J>O=6?"A@&JH2$CU2]B^@'S%E(K6 FJW!-5H]*"+90 ,?+FQYZ["7'N@GLC%_,;T:0LI)B0&HC]=]'1P*45,M\?8-=D[O"P&TL(O(MN>*W01VK2JZZA& M" TF0OB0!J@S%\):4&BTG>9F+OT9\846PW+BUVNG_ ]02P,$% @ 2)(O M2&ULE59+ MCYLP$/XKB'L7#"9 1)":1]4>*JWVT)Z=Q EH 5/;"=M_7[^@;&06-H> S?>8 M&7LP64?H*RLPYLY;735LXQ:H:T;];7)%NXP*WGW@IKP67$UZ> M>0/O7-:X825I'(HO&_=,[Z@6\5? M2/<=FQQ4A"=2,?7OG&Z,D[JGN$Z-WO2U;-2UTT_BGF8G!(80# 0 /R2$AA N M)4!#@$L)D2%$#P1/YZXJMT<;=I= [3* PVQX33&-V&A,DJVG,OL>DTYB#P0P(3V1B32=XGP[4Z02: M'CRDTRA,K"TTYDN8 CAO%%H-0JU4>K;C%;:J,>D?A1&\T;0:@25"/#C>8'( M*A#92S+&'#0F2N8]5E:/EYG^#)9(V%L4+.C170_R%]?& MWJ8@-.^N<(&$O0$!-!)P.MZM <5PM-[31O9&!9$QBJ:WS-: $P3$#R^O;S1 M"="B*_Z)Z+5LF',D7!PFZIU_(81C(>0_B5@*\1DQ#"I\X?(VED'J@U4/.&G[ M[X3A8R7_!U!+ P04 " !(DB])I@4)S[PG "5RP % 'AL+W-H87)E M9%-T&UL[5WK;AO)E?Z=?HK"P(/(0(OF15?/9 !:HCW:E25%E#T; M#/9'DUTD.]/LYO1%LH(\11)@WV,?P4^VYU)577TC*=F[V20$LK.RNKOJ5-6Y M?.=21]^G:28^+<,H_=TWBRQ;O7[U*ITNY-)+._%*1O!D%B=++X-_)O-7Z2J1 MGI\NI,R6X:M^MWOT:ND%T3JJOJS=NY3Q(L\2#[ZZ\I:R^ M-8SF03R.EYX+8TT[+8.5IM-;[#SF]\T[>(0QO!IG+>A-Z\^ MG7EA6AOQ+$\2^B!(I[ )?Y!>TCK[_G[W='_0;=E'3_PDPW#_ERA^B,18>FD< M25]W'LAD%RC<#B=HH)*12*G$EZ:A)*^\Z;3) <62N2]C')I/:Z. M<)/(E1?X0GX"W9C6#_PNSF"/IHK5O325=2HNH@S85TZS'%Y=):!EDZQVUL-[ M+PB)0%!-(H7UB%3"N$$6R-05LSR$:6)0W4N9+> TXQFN E<''/"Z.MIU$-)" MYUZJ9PP:N!6V+0.GR8OCFXO+B[F)4 M>\7PR\BD*$*PX"Q+)/#0)@WFCH2Y+WII#.GO:?@R.C]SCXYI:'&ZYJ.$35D!, MNX8MSZ[?O[^X>P_,.Q;#JW,!"O?NXNK=Z.JL_C)"NM?IRIO*WWT#F"V5R;W\ MY@=1.]:[Z[-___'Z\GQT._ZM&/W^P\7='\3>^>CMQ=G%75T-L^5)V?*\Z':Z MW5X7&5&@],KOQ,%)U^UVZ?\4K!->#OHI"?XD_>_$H.<>]KONT=&Q?AJ@T?9) MON+"@@DO$V 69"O" S4\DW#2/M/RG:+%)J6_AI(Z8$R 4<10U,8]K [23'#+ M@*/Z@+WG#3CT_0!Y!BT&V)_]( )CMPJ Y1L8TRC?.%L KI@"FDCD NQ5<"^! M8>'?=38MZ?=9, UJ\(8%C):QB$-?)NEOR=8"(ME3G]08IL;2Q+=/9+KM8(78 MN_%0]!<@:H!3MH(9+\0K=0S-/@CB/:EMU]L@ ET<(("*4SH,\?-P@D[!-/O/ M;4QILPW]LWCQU(\MF]KP]=-,@-%U#2-=Q='TJPU6UAU&4,4>L+(?AZ&7P$# MK702+W$$\&X[%>'@Y M&I-UK[W%TUZ]$Z/_N!E=C>LV]Q+<2RE0"CURS13PKWE)6IY=%&WP'P*.;A!P M7*+P_*G1YB.,8#W0,O [&4F,&=! _C*(* R1H29?[X/42*Z]=WD]'HNWM]?O MK=VO;=#=CZ-;<7$%T&,D]M0F-9R+ D$MB[@: =R&V=I^+V!^@>CF^@HT^_!V M)/;%&R\-IK1L/PAS5'O/T136F,!G'^Z ZZ[.\;S;)N!Q<-2V$5MY&":[N1W] M"#MT\7%D]JR=FP&(IG$8^*33#4^#*S^C $!ALB\:3?;9PHOF:,_%#*R!4D6( MF;7GN ^>XW[%,\[[HBR7'\R3&\T3) M',/C-L??BG6(G]_+Y40F-5EOT'A;?3#:^@,+?MT@_+J(Q!G#K_9/+(-]33BL MZ5"W^ORXU"LTT(@C;\PQ@.%BQ1TW:W MGI""/Q=7'T?C#=]UB0J0]H10 MYEG)K-3"I_!#C";06(&M$@S,K*BW'X)L(5HQ4ROPMW77"=S+])Z!X=]DZ=!)!LLO_6B*PKLK+^[P2!GE'F%,.IPC06MV_W%*]1K MO8ZSD2YAF(?AK4XJ:>< %DP FF2ZB M.(SGCP1BO.@1-FQ*"AWF"0#6Q/>:?^5L)E&O2YH6 88*QI!_#:AI/Y[M3^&L MG RP%EL/5\ATA=YG&#Z:3 &P"TA0?.^E4T"4;*<3&!8I)6V-LYDQ<"84G=6" M'<\$7GY$>\#([F9X_K)C;8):/*S7AU,/XQ62'\!>A]*C ):?3S/<)3_)YZ!" M(Y\\'O@)6-07EP&\@E(E[MZ+.Z!#Y3X=C%/R?O+> / ,0H,\._:[G_^2BD?I M)?NH)X"0L5QEA)3!8'?$=:1BR:Z#7[KB 14*RI+/HN2)B3Y;.),)\ T=^@.L M7TXP4?P V#5\W(\?,,VY__6GQ!SS__[:58RF2NA73=@$U,5QJ17X AG9:Q>$Y84'(?W+.I%G&> MM"YW#Q?[^:_OD< $2>T ,0@.(CGE'<-Y\"5^Q76LW='J ?8;?ZN\ =Q".^YO M:S5\5ET-G+U8!F&(LZGX>?D0D!5X$(<'@2VQ?4@D&^9R<:T>"$B:A\"""]*=(-X@.;-8J<@LG'6P4'CK"[J >D!5X"MDRZA&\HR M/^[K\,C$2T&X]H C_@@'CB?IB!RJ$T+RZF=- BPS@"RO B0-"8!G.66T=OWQ;CU8[I =EB MM8I10_K((SA0)!^VH<5&A*@R]CA(Z$RB[AGQ_EW .= MK6:''<6:IWD,3 7#D7@VRE@K5Y8D;DK8PR=E7) 4>4O)!-3Y"0BH5#+1>GD M2S*!'M#8N22W!.RI+Y%?8&[G^NY,O/>27Q#ROTOB?.4*^-7OWP@ _8G(\"FEXB70+%BO]/EO'9LP9P3F>$YB;6?^E:GANC+C^V!N*\R!&)9-)<>O M@0.]B0>'?!DC&O$BI6UKD"3FVAN RDE3H%855X@; !Y3G&X#FN@#FK"')).% M11IT//# F1F,DA889>'=(TJ6$7+PRDN($=-\R2I)(6)]Q@\!U8'P<;!2F\>L M26G.#D982F@83Q[VB>75V2N;U9?P*IS:?%%.O[JE.1=@U[W",\4D^V= MJ!J0.8>G"3//X QXSB9GU>&2$+?;[8&>H*$VS&M&?XB37VB=*@R'(QT=G+B] M_DD'.# "O$7B--Z]=)HIM;!1A#5/LSS+$TG M W#0S$-UD#J)%R#0)3N9X1Q BQ_G$YAP I:M:IO8 7XDY;GNU*JL@D^*8+'A M&\?B&S^F=6H9P!WSJF&%64B:&]D!CHX<>EZ6 INIDF.*0 "&U^12<54(;!B MYC,0FUU[1S&8MV0'OOXN':SE_#,;+[U'98!YVTM4P0+5U%6U7]DXIV'C-(0T M9T\BQ!#Z8I=6!0'(Y@BK'B"=M41/HA,RB^8_#G*O1@#3^!CD?>\8JH MLV)SMR[\N+X)T&2J@[ >%ZAR]*"V.#@+CR+Z6L35SLA<4&Q&7@ M=@7(7:2<$XRON( ']#S=9G!0T(HJ:B1J.(QA@B%B?6QDCPI/8]VTBS>4DPX MIC-!D!//8 PX?&9]%B C.3,/L%M"\0=>/.G?@JWP#'1 @^4ODZS#"@%$@J>+ M !9F9J,'2O61LDN_3-LIC@ICL(DUCIK($"=/:\8/9P"*_DAZBW!*!.LB\Z V M'38HS:?(8"!U] K]FIQLW[90? *.07(/BP"0L!Z#W'-D8V(&6>,1UJ#S)'[( M%AWQ8\$$P"3H\>(8-J,T+L5!UB:X7N"9^B+<$G>4% $H4HWQO8P8O71<-8\9 M=WL?=]NY#_1!^7*%NHMB$5GI_)3L -3[%4M3A-:CJ/)(2QHW2/.4EB@=M4 $ M&2AC1 &TG)G.4:QAS$I)(Q8\[QHN;3<-FE$-F:4M*&J$\= Y..I80H7: ^PE MZ<_,GKH6R!WGRZ6* (S!\2!+AU<*ZB"Q$1D..L[V(P@*5@9+IS&B5<.4>>3E M(-\V2MB +O%8883$)^8F!Z,H)4:_$@8!O9R*.T1X?AX%$)0Q$U><-<2GG\O+,+;F4[+FY A[0F/:S.PR#8F24'QO\1Y%! MIB=(A.$, DY6,+E3DAEB*B4!CA6,MYD=;,@2 WO,LE,[>MP1'[#"9^:,4E:@ MO+U[A$. M5V 5J^[@9#6R-I"[FDU352SI%!PR-$6N$@33]'D"(L< M?6$"W]%E1G8*)C%76EC\P,OCK(06%6#!$$F'52>:#>+4VB40!<+CSFV0_@)# M$X Z4W$G!E.4)ET:'#$63(E[ M$2;FB:&02,8AV3S >E'U,X/B>^0A(K:U:=3PQWF0&KH5@(6(9&:#0\XC*DRB M[*Y.^F)!M !Q0JS-"R 8[&6*KW50EK<7]EQ!-7WTBIB.LS;NL:7>AT-]B*W# M5RI3Z?3#@V]IAPXXCDL[4IRS0UR$9Q:GLCX&C3 XY!&.#K^U+O"4<^#UJ$@' M&=T/?+)(Z*B#*OP3>Z7J)# N W:X(1?ZG%V@^4B5EB;$FG7AH4](N '70[X M06VU$J>1?'4;R7D'3V_,'9Z2ZZZ60$FSVY("X,%>(AI+4,/QSM7A,*:58N FN0'SMA03;HSC: MYZ0;[@T-"2_X"29-HKEK0L?X,VEMF&VU4NEX>PL?9!BF#66G#A/- 7'V-9)@ MDFYS*!K3M(YZW,JR^=EMM7E8;)S\A0R)/Y)%:B"U0>!P33Z6L<4]R0/\I)J-5 MMA>/1(FJ>:^R(=J6,>2TUOQB<'+$3J7.<&S28EO&L#N"2W@J;-+.=JX@]M!) M=%]7.V18(\*[@* 265(%<$!C<58(?# NIU*S"&6+Z&=0[2R*>&DF*M), 1- MD0O7,A0UO;53BTB<"'RE#NU'E>/,SL,FH,NA[I,$Z+3KXBZ<'"_U1;BSB"H M,85Y6M"*RJW@'PXU4KQ(+P\X>N90R,1\:'9!K]PBOE2HW,!<6A<:WNS53JAS6;HR1GH4FJAW^VZA\>'&K.1"$@NKF>"^1#L4G]X M8>KE+.6/A?UD=\3<\ '6\25&88 5T%01+*N>)2G -(WQ5H$T/C+JV8+HCG.F MK FE8]/T>@;S>2%HX6A M-%A,(!]MV3;+;<%O+F>LY&A +;8!QY]F[]WR??RX=.>LJRL)N\O!1_['1 M!)0V#('&'M$H!8NQW#U( MBATS6GKMX-5_"NX4$ 5+:OHX^@#_ M)'@]H%3$E!452FF \7^".KQE)2U65@MT/,6](&3)>R/TCA'ZW&1*R+XJ75RV MKYT:]:*@OI!S0+]6)(('EI\"+F9,.)06)X\Z;E'X_472U"B+()JIP%O"_KF) M3CD7%+(KPE-6<+LLP6I_4E- 8L<#S1@*(WA)\JC4OPX[E/LK<%BW?O';+GQQ M5$2I,$!:.ROUP+CN'J/G*5UU5UA#0SSRXI-@KJO#C!-K$:P#U#"'T1:)1+2A M DUOA^,W5HC7&:M"OA2VRB]2JWO#\=E+<=+OBK=([T>B]SU ^5R=#4UT;N(] MJ7.)(N/T\!Y-Q% 6IOXUCQ&<*)M/45Z*5BY5?0;'FQA;2Y5W57[ZLIB,]3$Y M63[FABAHET<8]("!N4R&3@$Q;+'Y'453'VBZB%8YOD"V#6:-'"9-&-*4N*@8 M!'TI>@6!\01EPG3#*,30FA/0@ QH!N.:4,!9_\M5T^"^EZ>G!AN Y+ TLG$M M];W[3M2',-LC-HWG!%']$*A&@2;Y#N:K;%AENJ=MC-B3G7G'-;$JAP3WY7#O**1T$G>%,Y2D6P"9@J M,GPQ*/A"S^U,X#W;\=*)44MJ;<9$\O.H(*+#XD(O.D68M4 S& C HS3^2[Y" M"Z)TD%J"'9$E3PZ-;D29>CM58=JS4%S7Z-;"[#IE4Y]07:XJC%$:S2 R30+X M[DI1[K.B;-2+ME[3^J;8HE0%20F$D"K;YZX==@BMK+=,34OC;*:@I!Z=G+B:F8E<>$R/>Z4N M.IRHG!GAQ'U17P3LW92]?@Y+X]CL<6(U1T:3$[V*?EUGYC":4^@TU:+/!"&0 M4KS+O1[L,%IF;T(;<+/\WPRQ"%^C)""=8!25@"-5Z3I)G-LJ2_@-]QBE:H%Z^"LU&+#.M M7E#DF@?:)@S":M].SHL"'"9$VS#]$0DK!TJM(8NL7@HDI;, MXZOTSIT@:=$ ME5%;G'\N0@2J&A6PEC@^Z.K[N#S R$NP5"9U]I#Q7])UOLA;*E7-1BGMP254X53GY M6JV)?8.0M'"0ML^CDGQ54Z!7IYC$>49*HS#)0[O\WXX*Z;P*,1D5^K7OFJ-V M;:9K.\CG@C M([HZ#IKJ! $U;3V5IPN[(A^U%U%4 M_)#6*G&%L#(\SCP/?"WOR/WC?)*1 !P<=_?!#3I'EB'9L):!2^7KX-<*KIT5 M%49D"<]T#GS:EEY*S42'-)%2314_3;3X:5PVBLYB)1TUM2?NF'1UD6UU,*M* M'KBR]R;PE57*.IH+#RC(0!=J=$32JJ:E1+*^-&PSWB3/^&VNFHPC#+UQ46QX MKXUDS'9J&2=%;? ]UY*@G:(25K W9"SP%^531="#_]-JVQ0A6.Z/2X?#:1=Z MG>M@HP5A+=<\-4DN_8JB2/X>:JV6^<_.:Z( 7_-)$'MTX)7/JSH1/%2UO@#73RR MJZI*$QBQ!6N>Z6HT7".QAL?JR"E?"/39NZEF1U*K4(-&U:>H'I?/"TT%7B'D MJF1+)6>J^+1,J,.^&F7#$'A@M4-365AS_1A91EV37:H-0%)P-F(\E+#" PUU M'21M@2<0_2?DH\ *IIDP"M+<@T-K8?:@$)\BT9BTE?BC0Z!J[S&&/;4*#5%K MZ'N7J.^L6U"ZKH30##*(K@8HYK8]1 Q6*860&EY!5F8\HL] &5)0A2E )(Q+ M*C%L2Y,;)8H=-U1*^^3P<+_7W3]\JF;30*Q<4Y0:6I1*Z#@V+]$IZ52 M00U)A@'EC3J.@\\D7QUQ T [5R$!D":TJMW][JGSI&65S;!'^F4\.H/I0VOC M4W+TFNN]6-HUW0 N$\1LOB1LD'(BG(%TCI#;U5K.K'VFDB +N43.'9V_&]YV M:N6EP_9[T^8:\EEQ577C3:2#CAV-W]V(W=V(W=V(W=V(W=V(_<>Y$4OUSR9O MM,J!=BKLLE@;+[-A#P<^)@^^;FC#\?EO:LHJ:&/OL1&V,4)R2C7^J$4^=,8= MH:O[<5=JS%/V\K-%:0;5CR3ID.%6Y:66R<"T(7 RL!@%H)JK^PES -C#7&Q5 MZVW\F"K),#"B@+-6&+1Q;%/$^)1P1<@"A2/&7*5O%@6;-R3QTJP:UV4\;K--39QJEUME$E M%\7] %(_%'2G&/R+OGMZVG4/!X=V>!5G+V4G6AOGT+5T5P_WTM:NUNOB#;5L$B>KBSR5F/??HL*MS<>8;=#'T=UAA!.N,_-HJ M[*;V5Q01O&GNT4;+.NDXK1^(L];@(NER*BW0]T6,'JPV;'_M5(<1JL]IM11J M8.Y(<'5%6*2>[4,_[)^X!X,#O!F:,;_61CITS8Z;5#?0U>M^2Z%SK'=R2Y'H M6B,M7(9'B42:L]OI'A2=9@D/^G+F@8+O8%+*'?0/VI9I;\9!D<#<9J7]XR/W MI']HK;0B9M5% M7.%RUR4"RR(W#Z_LEAV\+.0:YYTWMJ<5LMJM<[<8_Z76M1 MU8'^-Q;6LQ>F2&A;V'MR !4QA]NMZN#4[9W:BRH-.#%L[[7UC.H<5Y@B??6F]LN:3^X- =X-\":]<;)U]!;]BK M.K;/2,V_K3AMN2I@NN[!.FEJ6-,72].)M2PF8"M9.MIN2<<]]^2HUR9+IU^9 M^3QQ!)^:)J<*9JH2(,JC5\N1K=P7D\K%"D[KGT, $W':/76/N\?.I4S3U\Y3 M_I:"V#OL]=V#TX%XJ;ZV&[)&Q1]F6#."^LLU.(*YZO^$/P:$%;+NP4'/47]0 MPMF*;D6VG;O?P4 Q#B[\<#YL#3E M@@J5$;+XD6\L%=F_(ISHQ _4\H.R>51(>- Y-=$N&RJ; *.%:#M6NI7ZV92" M1E9&J :1L D2&5VCK<982VLG;8I&& ,7N\MSWX$7M% M';3L<@=F+M_,>O!*5[-J:7FZZH@Y@:*&2%6SXGM<::86Z,T3J;O<8-$ =R.I M=A2O]YQHZ**^S3N\B1L9,2+ M^M$:/FM;=:V-B$N(O=8:H?V5G?!>DB+D78 MD&=5^49:>9":W9->VQDI^[ICW_N$U[:G^.0VU:N8=/RUN[3C^[3C^[3C^[3C^[ M3C]\S+M./[M./[M./[M./R7Q^Z?H]"-VG7[^:3O]5,%]$5BS&O^TOK3K#K3K M#K3K#K3K#K3K#K3K#K3K#O3/VAW(1E=_A^Y 5?2AF@4)JUE0RRN[?D)_IWY" M+7]G>MSTAZW_7[8>JA3N'*^/8[5W:]A.5[1SZ0>SZ M0>SZ0>SZ0>SZ0>SZ0>SZ0?QC]8.H=<'C.(BX3N9>I-T1!)2FL>[>N02_'_#9 ME9=P(7P-7($:[(CN@-GYP_A<[+VHO3/,YV!C^HQI6M[YMSR$<8[YG:L=$CMFO(-EQ![]\>4^J-\UJ.])M6@FVX^,B/&3* MH6D382WFS NGX.S(''OW!>G"!9\%S].+VK>M3%JE*%97&:JRB^JW_<-&0EM' M5,7%U0]ZG8/Z*+U!Y_"T/C8?%-;AZSV?8;'+GP6R? MZVFGFR5RXWGU.B=-Q_6H[P796] TZ;L81Z>;CTFTC88Y\]*%F&'0A'JQ[ M.%CWL%_WD;<-1]FA*%>'&RA*\WI-)W9^H]Z0LQ()JF79JY&@KT7W-%_F7)7: M0OLS3EST:B?-$E8*D=0VB2(FMT5E\G41,6E32D7$!.]\8L$-QK=UQ*3MJZ+B MU57U@:ZI!VW[AJ,MSQD)=,YSEG9IU8:Z1<5JT7@6_6U'_\6?U0 M6PA5X5G[<:WN8XOK2+8NO]1>@.^NKXS)K[Y\V(A,VR>^>XA;)SYH1*=#7=AU M6UP/?^J2!HT@;-N1U]%\U#)R8?0:6*0=%93\HM:_7&(/__,EUC%>9'*9UHAK M;C+^)(*&JZ1CRJ2J#S_JLN*ZDQ04[=$YP='N+CSCX_>J85;S JTS;.U4U:KV M-S;[WD+DS2!/>==J;6TUMGY"'D-CSD:>TL%N=T7K.+<71O#Y,YV%TF28NPYDN0P79> MV[CN;!?^6#^ A[@M?!U)\Q:2,'ANO@ M4,\EIYSR^#):8"R+EIHC^:0#^$)2RJ?T=%+J688OHZTBMUQ@\=JK-,U^^!]02P$"% ,4 " !(DB])9NIRN*X! !Y%0 $P M @ $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+ 0(4 Q0 ( M $B2+TE(=07NQ0 "L" + " =\! !?@$ %T4 : " &UL M4$L! A0#% @ 2)(O21J'I'H_ 0 :0, !$ ( !3@< M &1O8U!R;W!S+V-O&UL4$L! A0#% @ 2)(O29E&PO&PO=V]R:W-H965T&UL4$L! A0#% @ 2)(O2?U5I/2/ P \1 !@ ( ! MQ!< 'AL+W=OD!50( )0( 8 " 8D; !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% @ M2)(O2303CI7/ 0 @P0 !@ ( !KB 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 2)(O M2&PO=V]R:W-H965T&UL4$L! A0#% @ 2)(O2216N 6C 0 L0, M !D ( !FS8 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 2)(O27&OASU4 @ ZP@ !D M ( !*CP 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ 2)(O2>!L&7B< @ @0H !D ( !>$( 'AL+W=O M&PO=V]R:W-H965T>O2+@@( -\) 9 " 55' M !X;"]W;W)K&UL4$L! A0#% @ 2)(O202S M_VB* @ O H !D ( !#DH 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 2)(O2&PO M=V]R:W-H965T&UL4$L! A0#% @ 2)(O2<;Z[.2_ P -!4 !D ( ! MR58 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ 2)(O2:8%"<^\)P E&UL4$L%!@ I "D $0L #N' $! end XML 42 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 43 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 68 160 1 false 32 0 false 6 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://angiosoma.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://angiosoma.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://angiosoma.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://angiosoma.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Sheet http://angiosoma.com/role/ConsolidatedStatementsOfComprehensiveIncome CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) Sheet http://angiosoma.com/role/ConsolidatedStatementOfChangesInStockholdersEquity CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) Statements 6 false false R7.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://angiosoma.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 7 false false R8.htm 00000008 - Disclosure - General Organization and Business Sheet http://angiosoma.com/role/GeneralOrganizationAndBusiness General Organization and Business Notes 8 false false R9.htm 00000009 - Disclosure - Going Concern Sheet http://angiosoma.com/role/GoingConcern Going Concern Notes 9 false false R10.htm 00000010 - Disclosure - Summary of Significant Accounting Policies Sheet http://angiosoma.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 00000011 - Disclosure - Acquisition Sheet http://angiosoma.com/role/Acquisition Acquisition Notes 11 false false R12.htm 00000012 - Disclosure - Intellectual Property Sheet http://angiosoma.com/role/IntellectualProperty Intellectual Property Notes 12 false false R13.htm 00000013 - Disclosure - Advances Payable to Related Party Sheet http://angiosoma.com/role/AdvancesPayableToRelatedParty Advances Payable to Related Party Notes 13 false false R14.htm 00000014 - Disclosure - Advances Sheet http://angiosoma.com/role/Advances Advances Notes 14 false false R15.htm 00000015 - Disclosure - Convertible Notes Payable Notes http://angiosoma.com/role/ConvertibleNotesPayable Convertible Notes Payable Notes 15 false false R16.htm 00000016 - Disclosure - Stockholders' Equity Sheet http://angiosoma.com/role/StockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 00000017 - Disclosure - Subsequent Events Sheet http://angiosoma.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 00000018 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://angiosoma.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://angiosoma.com/role/SummaryOfSignificantAccountingPolicies 18 false false R19.htm 00000019 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://angiosoma.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://angiosoma.com/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - Convertible Notes Payable (Tables) Notes http://angiosoma.com/role/ConvertibleNotesPayableTables Convertible Notes Payable (Tables) Tables http://angiosoma.com/role/ConvertibleNotesPayable 20 false false R21.htm 00000021 - Disclosure - General Organization and Business (Details Narrative) Sheet http://angiosoma.com/role/GeneralOrganizationAndBusinessDetailsNarrative General Organization and Business (Details Narrative) Details http://angiosoma.com/role/GeneralOrganizationAndBusiness 21 false false R22.htm 00000022 - Disclosure - Going Concern (Details Narrative) Sheet http://angiosoma.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://angiosoma.com/role/GoingConcern 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://angiosoma.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://angiosoma.com/role/SummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 00000024 - Disclosure - Summary of Significant Accounting Policies (Details 1) Sheet http://angiosoma.com/role/SummaryOfSignificantAccountingPoliciesDetails1 Summary of Significant Accounting Policies (Details 1) Details http://angiosoma.com/role/SummaryOfSignificantAccountingPoliciesTables 24 false false R25.htm 00000025 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://angiosoma.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://angiosoma.com/role/SummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 00000026 - Disclosure - Acquisition (Details Narrative) Sheet http://angiosoma.com/role/AcquisitionDetailsNarrative Acquisition (Details Narrative) Details http://angiosoma.com/role/Acquisition 26 false false R27.htm 00000027 - Disclosure - Intellectual Property (Details Narrative) Sheet http://angiosoma.com/role/IntellectualPropertyDetailsNarrative Intellectual Property (Details Narrative) Details http://angiosoma.com/role/IntellectualProperty 27 false false R28.htm 00000028 - Disclosure - Advances Payable to Related Party (Details Narrative) Sheet http://angiosoma.com/role/AdvancesPayableToRelatedPartyDetailsNarrative Advances Payable to Related Party (Details Narrative) Details http://angiosoma.com/role/AdvancesPayableToRelatedParty 28 false false R29.htm 00000029 - Disclosure - Advances (Details Narrative) Sheet http://angiosoma.com/role/AdvancesDetailsNarrative Advances (Details Narrative) Details http://angiosoma.com/role/AdvancesPayableToRelatedParty 29 false false R30.htm 00000030 - Disclosure - Convertible Notes Payable (Details) Notes http://angiosoma.com/role/ConvertibleNotesPayableDetails Convertible Notes Payable (Details) Details http://angiosoma.com/role/ConvertibleNotesPayableTables 30 false false R31.htm 00000031 - Disclosure - Convertible Notes Payable (Details Narrative) Notes http://angiosoma.com/role/ConvertibleNotesPayableDetailsNarrative Convertible Notes Payable (Details Narrative) Details http://angiosoma.com/role/ConvertibleNotesPayableTables 31 false false R32.htm 00000032 - Disclosure - Stockholders' Equity (Details Narrative) Sheet http://angiosoma.com/role/StockholdersEquityDetailsNarrative Stockholders' Equity (Details Narrative) Details http://angiosoma.com/role/StockholdersEquity 32 false false All Reports Book All Reports soan-20160630.xml soan-20160630.xsd soan-20160630_cal.xml soan-20160630_def.xml soan-20160630_lab.xml soan-20160630_pre.xml true true ZIP 47 0001161697-16-001079-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001161697-16-001079-xbrl.zip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

06'IUZF?&TX,=E1VIUE7 M=MD96V4/"RELH]0I71AW?@K4@[)-"NCVUKMMQ:H7WZ[:8.C9&K)B$+DLRH1A ML#,WQ1+6)?77G:5/CAK Z^CITX>'!,M()7P[9D**NN MF^9SE*4#7'[:^B"7R+>$G]EZJ?!Z8D-/I,*\)0$_)QE&2>IL7[4A-.5IH+/+3,LRNN3^1M4K M$[Q5 6!8O EJ=9TLRQ"'!>M2D"RFY.P,;A8P5[G)P#MI=NQHZEJ5FO]IDQH8 MKKICM5ZDWH!*%99'-7:RGR;A+HEF!USFEEX2#)VL\-1HYO?I?BR9P6%KD#T/ MSX+\\6P 8O' G0^>3=:IE69GCEKMJE(X:;FI]4ZG]EC53 Q2&67://%"IH]$ M 3 L527$0>,IJ$&XTQ-/*^!J!C6=9._4KD(O3@T&^3U(UNC1HA<'2 MJOF^M\8K&&3ZA!.:B(=+Y?OK9_G?QILT1^5.[\E:5:AR"^:D"8: K>!J0P30 MA=8?%08Q*[ZT;G2TJW3ZH-L!?.6QMD4>#.$<0&IVK9D*\0%S[6M")K-1DM(% MPV5R=JX+=PL/2 LINCUP^@&]KGI]O3*L[DZAA>?9D4X3&R!ML[&]4JLI &# MC+<=9;E6NCE590D/_!XOB@W M7KP4&,SCGBMN;--*=NTOY, JC1@8)IFQ*:^[2$AF5*SK2S'E+HD(,@"#.IS, M-)61-4)?YJ-Y("%_YNAZQN]>0+=';FTK5CV!<]4&0\O6D'6+LJP <312*0(& M6Z_)4^EZ+8Y"]J-'2OMK-\ZV+Z;;Y%J;5;*:3JM=&6!8O"%P=5_+SY.#9R2# MOU5><5<*A<'KNN]"&S([ZO;I6>),6R=%,%QM@];B?4( >9],O3GQ5P&9S(9X M25,B;\^+A]]]X*5GZ6H7D3L,QD(J9&RN_Z63LF]GR:J M#(/=?@6< ;.7>BE#*_L6?H7ML<+YOZNL]#PP+ ^F1++R9891GJT%E[X%W>,$ MR!J]N%F0+SF_$,Q=,O#069OYJ^C,,Y_%9Y(=^)M5<-(W$W1O=PF[: Q MM)=-6Y0+9J#ML#*VT87EF_5%5KS8-<3R)N$?_->T$M$T1!@57RADPQ("/MXH MD%FP]+9'/")S&4D-.AU[FS3#K_F;F!7 D-H%I7TN6+_8"L6+K27L%UNW,MRT M^,-T&5#W9UL:S7YOO8Q5L=][*6I@R.B.57T<7\0IXZS,8XK+8.,)5X3*1_X$ M:%V]]8GF+5\P62/6MRJF_V==S95L?MUE+@,PAYV ZWP(:@P^0L*5#P:1?R9! MD(Q#MK'@_F&3V45, _8E#X96,8MW2XHEV;H;_'4RKPODA(XRM],'G'!. M^RN1SPZ1[TL2;G_<8&!T 3;S]LH@Z:IO%.V,BPU@"Z(9Y&"PR [.G2*Q5-^7 MI8NCOQ$O)7YNCR^)D@O6)MB=?;(!79L>G10,/MB@*6S(98N)#LV8-(RUU"U) M5@$_KETG2!A)V\5/:MN)5Q^)-2^N=SSNK@I(# M.4IQL.8\-X%>M%@&1,R0_""_@P7?+6%HR<]1_!O#D&>-;%HG&)1Z6;Y9*Z!= MI6DU>J=9*YCV"346FNA)JA9Y/&$8U*UV&)L6TJ7AW'P_L5D)O3-W*]@*DV4A M]75A1]:PI1V$80';V#[P5F\3>]?&T.W[:%6Z7UV(P.X,)8U\>2VYCM>N'?*N MNK]VF];\D<3W44*NFLY4VR W'W[E*:9%[MMR&E(,+-B]/#O^0M)YY(_#1T8Y M;K,F3R&)DSE=KMEI:+,6^IT^AFA;KO M23K$R9Q-O(_4)_ZGYZ\)3P^?;6(<-JQM"NC6:[AMQ:K^PJ[:8/C:&K+B[\ZT MT2R(GJ0#6)0K(EQHPN#L./1B@A-R0>2_I4IF?G2&)G)1[/B]HF-%:B\7&[3 M<-(9:IV+V3H/>5(*!N^V<=)L"*NYFZ([=:K:86-4?*]V4"X8_N^P,NKK)%=/ MWK(7[Q%_L\51DP_# 4UWU"C%(_)#GB;C)?JABG>Z> M#2 KF^2:#!A^&( IT0'68I#XL)_7#6:;M>GW7*YY3?G]J.)G=0$^V= M[>&3?KA:K +VTV-3@I1=?\FA# QS ^UJJ*C? &8RV$NU=K6]\8HO +W%6;># MXXJ]K-#GMD<%;ML K:6AW4LU(CW0O5$CL6P*?>Z7[,0R2T,C5B/2 ]U4-1++ MIM#G1LM.++,T-&(U(OW_8#?62,)=%7YX"]']+4#_>79MC4,&T/[MBN)[&HA; MUR)ZP3K?G*%QFI2ZI+5;!91;[3 MO4D3[,K6Q"0,AE=-")4=B8PVDVAIP%NS:)7DP=#+ :0FA]]:!<4\G=:R M4.K)V?^"9 _U)C/'5SUV#7B._8YXU=.N_ 6CPQO_/720>%&2[QCKP)_S[%G2 MZ_M:\ZC:715.EVT*7$F#&!*^RA2Y,M?7,3 L^2!,J4^#%=_<3WD,/5H_"!A& MB^4JQ9*R]>P'@P4/AVQ:F.^F[$ZW1KMLCLHV:A<%@YEM=ED;Y?U'E+(IB.(@ M>!:/E7ADO>SQ$HPALXX^^VF5T) D2?E!UJ?GTF\BMJ"A#=L7TT]TXG:5U((M\F!XZ0!221VCX1WZA6LAH6;EVC[MB_Y]JY@>DAO6:'/,,TS+LSJM M<6E3 )PUY7;PS8]\U=>]E.WCP@<1I5;&5X;5T^)X;8N.UNH?3#_;T=>[^9L, M? VQE\4>:> _8B9Q@Y]K*P'UKW!ZR()-N3&04D6@9YYR/)W3F&WG,-L)PIBN M2V&M>?C5Y$9B-9\7Z:5["C"N@VP(+5X6!3,UV_'I#W;W%DC<$)+%@'&XBF-^ M'!U'B3;TJ)-:9R%:6E2BL$ ..MT0Z8,D4D@>^&&0T2JYXU6NR]E2[R/RI"!: M2 M*3T .ZHA:8N%=*;1\>!K]EIU0[MO$]IM"NXU7?G! =]Y7C"6FQPKK!I=I^1N M@&ZV)17QWB< =XQUYN4RR&="$"EUB3W[K:U9O#\RJ:#-3%K+ J61 E#U];A/ M$2WDN:.J)Y)* K52)2.]3O5S$U//T699]?LCG4.US"RT* .E93-BC0-9)H:6 M7 Z]I"'RHR# <<)=R>1Q]0][.LVJHN>_U5>NYJUV5;JSLZMFR(;3C;)H[_1Q MPVKE9>!(%_P=[I8+K-$EQZ-/P05S,3&:C,*7I\]=E&OT\ MI][\)YG%;(C#;#CPFNGJO\/".Z/?SAND8.O.2H9![EU7ISX6LO)+[K9\3/#, MT='Z:_*8M_(//(4%#I_1BGT?>N)?B&3&O5Q ;FX\'.9;GM*G-&1*V=UA+:9N M)\9YX'GQBKN^F^._-RCT9*(-P U6NB8-@\LN$-68#4(*6(H+7I/UDB,;9;PN M>>6D\X2\;+>M/-L4TO7RLWT%ZVM0]Q)Z)^A6L!U]8:#[0_B1UUD?L.\2S:F+ MT&:$IJ9IG;%^XBX0:<"HGC"GKB'P(BC4>7L@."Q$1:])>NF9MOR>S MVBJ#_1L-Q9I3+)T-EX(NJK"ZKC5NLRGE_;@VI][Z8(7W:VTU)I?SY46\M<-W M[S!T>E(=8C4:P*K9 >(:9H2D05[01-ATYEU1UAL M$[-=)=]!WA,>*W#.5/-,02A9$H_.*/O][RLLK(Q8:15O?]!+5EOJB5<[96K^ M<(2PW(I&R_PJG/\F%F=LM1:+W^16MD>[I;9D2Y8<$DE^Y\AN.'+6CB-G!\21 ML]\YLAN.G+?CR/D!<>3\=X[LAB-OVG'DS0%QY,WO'-D-1]ZVX\C; ^+(V]\Y MLAN.O&_'D?<'Q)'W_[0M4DP(C'V/RTBX%0NDAD:G,2'Q5W M3=FX>+:3'X=^W^S?I>,(*,:[0%4<2-8=*N6/T#V;TU;A$M/210;K1]YK?M7? M6="CYROCW7AJ NY'#4YS)U:\-8NAR89ZK>< =%67CXD!=V^K&BC1"2J7D=7. MKSXK+DU00BR=,RO]Q*>VF#[04*QA8N)%#Z$(8)N9<)J_DR1"HW"\+F365 'G#0IY=(*9W# M@%F!!?'/E#[0R,#J C- LX.'7/HR4X?8PHBK0#REI&/*0RW\C7FJPV:H(,)J8\#7; M:]XO"Z[.]]=JPM;*4C"P$^AB(:B*71 T[R M\-_/;/3%,3_Z6(5\8/)^GK'O$/GFT$)\2[]=?4L>2;@BF6TS=VQ5#F@W:D&: MY^JJK8VELNK+7MX(E_OX/@^YBKV4/HIE0C]]*0X"HW@2$H/E5"2 ]9\!GIO= MC#)M?D#::_O?/44-[5](P&S_.KR6[9\^1;VT/W_S0#VZ%, &#S$AO+:&KK ) MP^H5!Z1N';0L%X1P7E(_?55:0]_@9XXCN8MD)E;"C'B6[+#B9\YW#+(B>RO,;G\3HQ',Q>,9A^3[&"1?P6K%/N&'\17*5^34+[?>9J3V*8L#B-Q$!/L/Z-[ M0L3^';.->C)GQ7 (Y'L:LYE>VKSUE_8^C&Z)O_+(SU'\&UNV&"^B&C7@#@H; M7/?%'2M#,)Z&Z$D657YH \@LMNG)@^G#[7H/8(?);3KQ+[BA8=@NB289EE8* M6"=9(%JZ)]>2AI;WS8P[-:QWN;UWSV;IRUP5P75B&]1*R!ZA;ICXU_$3\_N? MHVT/-;9PA;P5-TPB,)_9^U$CU)G#HQ%@03%% A:73/"41^29_U+=?['(G<"O MAQ?89Z;@$=- ?,39E:SN%]R5R#_B5GPX_.M?C[]\.;ZX0'+KLG_BG+D0YZQ' MXIB>FRD24(EC?U1VL,0Y=R'.>8_$,;U!4R2@$L?^TNQ@B?/&A3AO>B2.Z6&: M(@&5./;G9P=+G+B?.ND3CO8!/G M'3CB[*O3NDD&#JJ;6^-6,X$O.]Y3[ZOWO]$DQ=\H>?K&&HP?QYLC<9E%8?5N M(\X#\*^\$:'!8N(+[[,IB7E:;I$^4G.D91*%U2V-.)5W"P\/L<@+PV\X^74, MZU9^)/F89]',TF>&4@FK1/!L>YWT MPRMT-Z<)HBE9K*_*TIC@9!4_%R4NLVR@/D\*S;4S&HE75Q\1"8B\5>-7=6$1 MZ])8">'"=R2:('MPQLR->%PEG/FS.'\9GQ+$I,7IN7Q_Q9]=B8ID;\P$1NE$ MF/P!D;^O0/&['!W4C>9EC0-@NP:N/J-D,R]D4;MD=SZ<$%.$F*-Y/\D0LTWI=,*9V9?#0G@3#D9ZN#NQMX.?K>WAVMO!YO96U7M8$9 -_9V)X/BG]G>NN_?!@>R?QMT MMG_;!;E^W[_M,LO%@#]Y3"P92BL" +(!VW$I[!521RB3ZZF1VQW*NFL!ZHX6 M8.M]-,E.7YDRRK6/$-='O D2SA"K(Q>!XEY= #JAQH@_7CHJ1E++[4M!D>5 M M2\%G!*UN.U:-_VIP2EH<5A-K5+&_?4M-/27#X2,[FNA56I7]^ :6@+N'I[ M3RLK%RF,!FD:T_M5BK/$-#<8!M79?.36.TTZ, >%':IEI(C)5HKWM1[*@^+I M0O<8A0!U@QF;LK@IXO_EHGVW^3CTH@6YJL5_M(A!;'<-.G/+2V'TDHM;\Q_O ML?GS-S49"W1-7Q,!U.PF9.H5?/;R)Q/LJ:UYR)68S!D"^DADY[.]PV1VA[_K MVMTB#J@/7%"J*<%+.M5A(+93_,B#Z1_!FL*M![M&H5_/P725&9NRGLK.E4JR MO=DGCQ^AD0LB_QV' T_$&$QNB4?H(Z[ESFRC!V@4M8*KFC>IA%[FZC_P4[Z\ M!+0N EPG9E&"L^B"*^(W; DW*^D@.MJI FV[/H_"S)?6>;[F_C>G:B/D,W2& MUW#RZ*('NJ\M?S(OGF(DSE_ $I]XG]Z_IKPF,_% G=01#8: M1B'[8,4^R_X8A=KAO5V)@+I^1Q51LE>SM1$O%^4%\UNDE[QLQHT?T'IKL2[_ M"*V_ :V_ A9EQN$C#WBY0\HXE@B?,FTKTI(R1?&'1IE+&N+0VR5E'$N$3YFV M%6E)F:)XL)3AX-DZBO_#SQ,?<<#OU&]$/+[ZI*S=>;?0!T2'C6"K"4A8Q_/E MHOBA5,X1DB4AS%8!^:)I'7TL<_+S+YGF0,;NK_@&58?CYN4! MZMR=5$,=KD6APBM!Q&,N'I"M"\Z]*GW$^PJ5RRX&-M?ORY.!,S:A'(ZHQ7"U M6 4,W:/6/INE 76W TC%"V*M(CN37]#G6CWUS,4Z)I]#SYBE ?6, TCE26XI M,B&4GAFM(S$Z](Q9&E#/.("L]TQ)!4S/;&/I[;VXFY(!]?B.*[27Z;$W/MER M"9Z>M,NJFH![:,$TM[/ZIHW3LGA_[ZYU-8NH!Z0,S,#6X M9DVRWY9V#T('KJ7KP,PM?0:AI=VCMH%KZ3HP7KSJZ:J9W0[;E*L>X+*\E=\_L M2P5-01*G*$+#PT?_^@5(2J)$ DA0A)!RJQ^Z;!D)(?/+Q)&92/SU?YZG@?-( MHMBGX2]OCM\>O7%(Z-&A'XY_>7/?/^CTSZ^NWCAQXH9#-Z A^>5-2-_\SW__ M^[\Y[+^__L?!@7/IDV#XV;F@WL%5.*)_<6[<*?GL?"$AB=R$1G]Q?G6#E']" M+_V 1,XYGGH;TD?WB48_XK<>A777IVGDD45?']X^C]B(+]R$_7)R=/SA/T\NCCZQ_QV_ M'YR?S[B_YV\R\G_&OCAC\_\?P]N3!R&0QA_ M?H[]7]Z4^'DZ?4NC\>')T='QX=^_7?>]"9FZ!W[(\?#(FSD5[Z6.[OC3IT^' MV5_G32LMGQ^B8/X=IX?SX2QZ9G_U)>U+(XG]SW$VO&OJN4FF3LJO<80M^&\' M\V8'_*.#XY.#T^.WS_'PS5SXF00C&I [,G+XOTPK%M_JAF.?QG3J,E68'O*_ M'C*$TBD)DTXX[(:)G[QPN*)I-EK&0=;=)"*C7][$U T/./Q''TZ/^'?^"4*; MO,R8?<0^5^\WSF'389[3,*:!/V0Z.#QS R[?_H20)%:-44EH>H"W;L1$-"&) M[[E!X]'6]F)@Z-Q "<TJ: MCEW2E4DFV!=/6%L27X7]A'H_)C08LA6A^Z^4V57 7UJK$F5 M#EH:<+XB![UH[(;^[YFNLMGL+(W]D,3*T<*HVQHJ91L0)A^/1,J9N:YM2\/H MI].I&[WT1GU_'/HC-A^Q!<#S:,I6@'!\R\#S?**4G%XO+0V]XS&=CWW(TE;3 MM*5!7(4)"0+B):D;W$:4S9!JNY;1M"6;X2-?;=A"\^(^!&1 [TC C9 M/.KQ M@8A;'BAT3.W/<.QHD/B,S1N:+%@&S&LRLK9L4WO%,+XB]-.'F/PK9;-X]Y%/ MY>J)H;[]5F>O=F/NJ/5Z6,;VTMM:3?IK&5&FH[9\/ $"R)PCH11;V6H8,%J=F-LIZT]Y8%[ MD UY%I&8;9.S_<,U^V"%A#PG)!R2X;PC/O)-?<'L8][)4?[?L7/@S*G*/[KA MT,F[<,I]%$.?#SZ@WLIX ^XEIY%*% MD1XV&6PAV\QO'Q/O[9@^'@Z)?\C&_X[_P!EY=W!T7'CM_\0^^IZ/X8Z,??[5 M8<(C)34C9TWK6ZX/M*P2GL0G#-&V);\BIG,\]_(BPR#2E,@",?X4!!P;0.& M.1\#UFV]]%=; (5^@DGH=3S:D/4@O&O-0&*_3TFL==R M:4/+&-"3# MJSA.250/BH($B,Q'3,B I& /GE]ID#()1B]99E@L@Z72% C'S_C@$'!M\320 MV^\=F=&(.R'SU#7IH4! 03E$SY0Y#*PATVF(^=L,AW32'I.6VL(/J7A@Z*6 M97L(W*8/@>]=!M2M\[(L1KW2#"I]A(?D&G8MSDQT.J5Y+E=_POB.>VF2)2,S M"Y7.3U(Z*#JH3M-P@=@\].5[P/P0=,D^$ZPBDN90<% =OI7LV\>$[\O!B)0: M0_% >1H7L%Z#QE\/*]Q=LP_,12#4V=HKX8<3Y\!99(FRG\][-_W>]=5%9]"] M<,XZUYV;\Z[3_]KM#OK.3_D3 F2H@$S:WY_QM@(^48!R@K[ !7 M(HO^_R8&4L=A2?AL["/"_CB\SKD6CC ;7D(3-\A:6H7MB@F;[=:9M>?L,9OO M/GM!RD_87R@=/OE!71"Y((=16PLEZ&PS= 2!Q.(>73_@\_0EC?IL@>T3+XW8 MQI;$-S3TE(8(HK86=M#:(6H( @=T/3]@NZ,O;CQ/TKU,@^" M>D^OTX>U0(4.C/I"V11,008B^_Y',E0/IP8;3@\GMQ>U:"YRVH11HW#=A[/- M -/IP%ZHHQ7(]&6U*Q/F)A.ES1C)QK!JB[MUX+-M>^ M^^ 'V=Z+:6/U)H1Z6P/OP5ZH9G/?LJZ<<,S"I5<\R&BB"QGPPVC (443M MGYZ[]HH;5(Q5]DF4LJFEPH#:TPGJ!(JL,<<. )IZ]Z>&C%""6[HQV0!5 344 M3F,NG$WAE$K%T+FDN!C*1E"J![)V]%AK Y6S,7\+7,XUH\=D%1?IZNUAB"W( M:*#(&'.A:%N 6@(XD!)<\U6BI:(#![?1( :3! [4^A,:)0,236]H>.:&/Z[9 M=,#W4'4UD&K274#44 2-^5JT$=21"@X<><4()M8$:G6B]E"LC#E0M+&2B4A%"4L;I @)+!89*]9$*BZK$>$BX'D$*AW(;/ MHPF48.G@ %.X&L#2'T#44$BWX?=H JF.C'"@6F(8M%S",=J&SV1#)_+K62ZG M4S_)"GSS)&":U?HCH2<%54H$!7D;[I=FRZ12(CCLKTG(KH4@W>DVO#!-@-N5 MT%SIIJ3JMD&E)10C@Y=T&IA3';J/\ NNM&V4C9KJ8 M[;..H4@;\])H(]V2+(UE"I9'UR<1GV5$]I>GS(D)H. 8 M<\BT)6L*XW?KR'1UD>EJ(F/,%;,E9+H()]/.<)@EU+C!K>L/K\)S=^8GKN1. M@I BJ(Q5XO^\4W..Q* /"^=IEF8,=._FN>5KFG,[U/T1@/W69J*H-<1%%!C M#A=]0)O)"@?0=[R*<4B&73<*V>DE+C%S04:^YTMV+A!:*)S&G"W:<,(E@@-! M\9LPD$,='"%CKI86CF^OQ<>B.M>"O&<"2BC.6+TM4-FTJ@-X2JK4/RFY4E_E MM%E]%>>GE;[W]59L77BY(/Q1X5+U?NUK+Z4>;-69U\*B/F2E*25#ATW%,*ZF M,]>/IO7Q*-Z!!OTNUM/19!'3CNF"/"17(6,KJZ]U'[I37B_S=[:_8Z=LGF L MMC\ J>WZ.QM8'E@PADQN]?N7T8V';9G@WL4D,XZ-#,_9F=E"T($5<_$(I5 M(MN%?=I!3R0,I*AE-=9U$)L3V*X U"9:JT) BI2\IK"(M285A0TZZMK#S'!% MX;:BR/HK'93>=HF?#<#4$Q%&6.%+GHK.=HF?UF TM?#IA/ 5:YHPLMUH:3-7 MWJ?I&0$LD^UC(E^]%(-O5!8?G2M%3SK;S*]H:#;=9F:#RBT"Y,T6)LW,IH[8 M>E4= ^C S,9J@&?!==P;]68DRK/XZX,[[V3!G?Z _?.M>S/H.[U+IW?;O>L, MKE@#)&7T\R2(Q>C5D1PA 8;@#:]&&=^11Q+*,G(%S2V'911(B"(Q=2SCV'D7 M9A..BS+*@(1;"8GM0(PF/"K><4!T3=R8K(]5DLE0W]QV6$4M; IA Q,PBT@J M6WW6(GG22STJ.MM1%%VH8'+ @1F_RIF-56E'U9:V(R"ZN(AXQ8'$%Q(R=KBZ M=(93/_0Y*XG_2)3 * EMQSIT<0)* @=L%>8T-@KV QNZT BYW?5,R05CRP1K M )#EQK;C'0WW>E5^=QW*&QK25>X*955OY0&DMB,A>C"#98%C,IV76U*N>96& MMB,;<$'7%Y@2KVU &_R4VV!(QMP3A, *20*92M>:68^&:)I7'9.[/G_.+ZK, M0Z-G;NQ[;#-VX0=I(HL^*@FM1U/TT 4* L?4^1OQQQ,VJLXCFX7&9.7Z9\EU M#0:S:7_6 S-Z&&\F-LP!@)IK@_61@/?P2,!Y[]OM7?=K]Z9_]6O7N;IAOWF"_1J.\\?0U9>=S7VCM?]\[_ M]K5W?=&]Z__9Z?[O_=7@'T@2 $JR:%:+#$1N]1)^,<*!HD;Z6CN585>,PL@6 M7 N>RF7\58[*)WX,@#";)E?L1\G&K*XM,F!6U$J$0&GXY7<0,*"0JQ*?_VG( M5X_.LP\!I)YL%[&IYZ2T;;/I0%H=VP5;TGS)'71!E/;"4U-X!!RC&-W7^1FKV:>JJ"1$ME.;6H"$D *F.#J-H%+ M0&0[O:DY7%(IX(!+4!U/!9B"S';F4Q/(0))H?%Q^)-$#C8G]Z!6@>IX2?'@7 MME.K&BF"KH1P6/)Z'3T5BJ+VME.NFD FYQT'/DQS(IZC?$'R?^N\4WB%UHHO:79TDB?R'-.%. MQ@'-*W7J1Z#!'=O>(+>C-BW)%]%"GM\U+\>^LW(H^4M]<79WJ?1JWS)HKECS MFW=K>UO>XO9@4]FB5I-\<6Q?3\#](KAG84Y1-*6+6E/R!T<\)I"\[D+#N6.U M!P37+PQ/$W420XUS48MI$Z#KNK!]HV,+=KYS4.<>9ZX5WT\W M1' G;Q/GG@[,N^;?,X@RCI1AGEWMQI/+@#X)RH%]U+@$U.E_=2ZO>[]A*0=6 MSHR>W1GK_(P<27 MQ9H'](YX['<_("N,#RA0PNH9P_PWVPX.&]7';0%G[!6=HIP9+\BT5D*K;L;) M'Y"1TMB.$V\-$0H6":8UI9._[>/F->SX8T#S1WYN(S+UTZEDJE"3VHXD;QM\ MN&0PZ4#UJ+5@N<@6$G$0MI]E=AL#3;E\;(?BC;M+6E!Z+M>]$X@A:OP MD=F:.:>K=O_6@^3MN5T;RA;'SI@SE*5O,#V_9#(JI7*(E4!*9#T.WC),%,XZ M)F WDX*I"0!!B-VH>K0C]5>Z"!4O6!E;A+3[MYX'T-XBU%"V..8JQHQ'R##F M$VI_0J-D0*(I]RR*54!" D75F&.V98C6WP]5R H'I)O)P)3IPY5CV_[9=I2C M':GO^O*3[='"(?^'IU(]N@&/D>1YC.N.",4F%]P+5*^V\;0[="EI(J?7J1L= M9C91],*L(4MOUE6*"CE4&[;Q:/QFVB"0S.NX0;P-9=#)-]W&L_.MJL,K2RM. M9[,@$Y,;S,74S3^ Y&&"J*&JL(VGZZ&JH",7'+O/NA%?A2,:3=VZEY-A8-9V M $[X,H:G#CAJ7"52P@'M,F[D2VOOE%M!03)764=3TO5O*Y59Q@(&SRX:N,\D MYH-313HK;:' F"OQN"$P(O9QP#/G:)X>MO!"AL.:(R%/XPIHG$: !^8V[QD* MO3G?6_.)LRVY&DIT+:59=.(XG9+A20V2O&EM2R@RQOQGK8F7*C@UBD*Y^$&1 M_S*?R-F_M%3-5P".3@=0S(RYM4Q@IB]!'--N(8->=,M.N<4OI3AA\4DA%C?H M1?F%OZN0B2+E\P^_^^8/"[=^*[ MOF0+18/A$=,OE*=$L_F.1&&]H7ZJ&"HG<>8T5@O.\ZQ]7O&%X>7!+M1*:*RZ M?Q]X28R$Z=4%31^2S@--DS(T X;K65!_]%JX!^!]6#8W-7(5QZ^N?##85C^= M3MWHI3?J^^/0'_D>XZ#*>JW5'1^M6UW1F4-'3JD[9]F?L^AP;Y(ML#+?=5R0 MV(O\V?+^\-I@ 9;9H*M=,]#&TL)@IW4IT2O&>+QNC&4*^RIZ3JWRR;L%E4F=!:T_YOU Z?/*#@,F>#8WS MRB^B9MX"G3"79C=VP^*"X0$,&41LV48;(5H-I$.%A,$>.\-'=C@F\WO4O+!' M-H-P9[7 ,$\K2VO1AU-TXB34*;IQ\G[LZ>R\=@C4&D7MVXS:264N,R5.#26V M;$IRN9;Q3F0>?U0K:*L>:^D>"L2W(FB_$W:AX &/*91>7+BA MR<*(ZRWC_;IEE*B=C'R^@NQ-I3T6 +8B)-@E8U%PC<%:) _BK1C*AXHGL43X M9Z<@Q50$G5LOI(RPG,YV\D)E:%I6I-&%]7+ $/R4!=\5$D)A<>E#3/Z5LOZZ MCSSP5V]O'ZN>^SF94]#9#32568!<+!!16(Z7E0<%#(\)2&P;D *3FEB8E'<< MI@()?2_Q_B>0?2[US<2TLN M.)+V5A)

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